Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

ABSTRACT

This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (“Formula One”).

CROSS-REFERENCES TO RELATED APPLICATIONS

This is a national phase entry under 35 U.S.C. § 371 of international patent application PCT/US18/038008, filed on Jun. 18, 2018 and published in English as international patent publication WO2019/005517 on Jan. 3, 2019, which claims priority to the benefit of U.S. provisional application Ser. No. 62/525,928, which was filed on Jun. 28, 2017. The entire contents of the above-identified application are hereby incorporated by reference into this application.

FIELD OF THIS DISCLOSURE

This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides.

BACKGROUND OF THIS DISCLOSURE

“Many of the most dangerous human diseases are transmitted by insect vectors” (Rivero et al.). “Historically, malaria, dengue, yellow fever, plague, filariasis, louse-borne typhus, trypanomiasis, leishmaniasis, and other vector borne diseases were responsible for more human disease and death in the 17^(th) through the early 20^(th) centuries than all other causes combined” (Gubler). Vector-borne diseases are responsible for about 17% of the global parasitic and infectious diseases. Malaria alone causes over 800,000 deaths a year, 85% of which occur in children under five years of age. Each year there are about 50 to about 100 million cases of dengue fever. A further 250,000 to 500,000 cases of dengue hemorrhagic fever occur each year (Matthews). Vector control plays a critical role in the prevention and control of infectious diseases. However, insecticide resistance, including resistance to multiple insecticides, has arisen in all insect species that are major vectors of human diseases (Rivero et al.). Recently, more than 550 arthropod species have developed resistance to at least one pesticide (Whalon et al.). Furthermore, the cases of insect resistance continue to exceed by far the number of cases of herbicide and fungicide resistance (Sparks et al.).

Each year insects, plant pathogens, and weeds, destroy more than 40% of all food production. This loss occurs despite the application of pesticides and the use of a wide array of non-chemical controls, such as, crop rotations, and biological controls. If just some of this food could be saved, it could be used to feed the more than three billion people in the world who are malnourished (Pimental).

Plant parasitic nematodes are among the most widespread pests, and are frequently one of the most insidious and costly. It has been estimated that losses attributable to nematodes are from about 9% in developed countries to about 15% in undeveloped countries. However, in the United States of America a survey of 35 States on various crops indicated nematode-derived losses of up to 25% (Nicol et al.).

It is noted that gastropods (slugs and snails) are pests of less economic importance than other arthropods or nematodes, but in certain places, they may reduce yields substantially, severely affecting the quality of harvested products, as well as, transmitting human, animal, and plant diseases. While only a few dozen species of gastropods are serious regional pests, a handful of species are important pests on a worldwide scale. In particular, gastropods affect a wide variety of agricultural and horticultural crops, such as, arable, pastoral, and fiber crops; vegetables; bush and tree fruits; herbs; and ornamentals (Speiser).

Termites cause damage to all types of private and public structures, as well as to agricultural and forestry resources. In 2005, it was estimated that termites cause over US$50 billion in damage worldwide each year (Korb).

Consequently, for many reasons, including those mentioned above, there is an on-going need for the costly (estimated to be about US$256 million per pesticide in 2010), time-consuming (on average about 10 years per pesticide), and difficult, development of new pesticides (CropLife America).

CERTAIN REFERENCES CITED IN THIS DISCLOSURE

-   CropLife America, The Cost of New Agrochemical Product Discovery,     Development & Registration, and Research & Development predictions     for the Future, 2010. -   Drewes, M., Tietjen, K., Sparks, T. C., High-Throughput Screening in     Agrochemical Research, Modern Methods in Crop Protection Research,     Part I, Methods for the Design and Optimization of New Active     Ingredients, Edited by Jeschke, P., Kramer, W., Schirmer, U., and     Matthias W., p. 1-20, 2012. -   Gubler, D., Resurgent Vector-Borne Diseases as a Global Health     Problem, Emerging Infectious Diseases, Vol. 4, No. 3, p. 442-450,     1998. -   Korb, J., Termites, Current Biology, Vol. 17, No. 23, 2007. -   Matthews, G., Integrated Vector Management: Controlling Vectors of     Malaria and Other Insect Vector Borne Diseases, Ch. 1, p. 1, 2011. -   Nicol, J., Turner S., Coyne, L., den Nijs, L., Hocksland, L.,     Tahna-Maafi, Z., Current Nematode Threats to World Agriculture,     Genomic and Molecular Genetics of Plant—Nematode Interactions, p.     21-43, 2011. -   Pimental, D., Pest Control in World Agriculture, Agricultural     Sciences—Vol. II, 2009. -   Rivero, A., Vezilier, J., Weill, M., Read, A., Gandon, S., Insect     Control of Vector-Borne Diseases: When is Insect Resistance a     Problem? Public Library of Science Pathogens, Vol. 6, No. 8, p. 1-9,     2010. -   Sparks T. C., Nauen R., IRAC: Mode of action classification and     insecticide resistance management, Pesticide Biochemistry and     Physiology (2014) available online 4 Dec. 2014. -   Speiser, B., Molluscicides, Encyclopedia of Pest Management, Ch.     219, p. 506-508, 2002. -   Whalon, M., Mota-Sanchez, D., Hollingworth, R., Analysis of Global     Pesticide Resistance in Arthropods, Global Pesticide Resistance in     Arthropods, Ch. 1, p. 5-33, 2008.

Definitions Used in this Disclosure

The examples given in these definitions are generally non-exhaustive and must not be construed as limiting this disclosure. It is understood that a substituent should comply with chemical bonding rules and steric compatibility constraints in relation to the particular molecule to which it is attached. These definitions are only to be used for the purposes of this disclosure.

The phrase “active ingredient” means a material having activity useful in controlling pests, and/or that is useful in helping other materials have better activity in controlling pests, examples of such materials include, but are not limited to, acaricides, algicides, antifeedants, avicides, bactericides, bird repellents, chemosterilants, fungicides, herbicide safeners, herbicides, insect attractants, insect repellents, insecticides, mammal repellents, mating disrupters, molluscicides, nematicides, plant activators, plant growth regulators, rodenticides, synergists, and virucides (see alanwood.net).

The term “alkenyl” means an acyclic, unsaturated (at least one carbon-carbon double bond), branched or unbranched, substituent consisting of carbon and hydrogen, for example, vinyl, allyl, butenyl, pentenyl, and hexenyl.

The term “alkenyloxy” means an alkenyl further consisting of a carbon-oxygen single bond, for example, allyloxy, butenyloxy, pentenyloxy, hexenyloxy.

The term “alkoxy” means an alkyl further consisting of a carbon-oxygen single bond, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, and tert-butoxy.

The term “alkyl” means an acyclic, saturated, branched or unbranched, substituent consisting of carbon and hydrogen, for example, methyl, ethyl, propyl, isopropyl, butyl, and tert-butyl.

The term “alkynyl” means an acyclic, unsaturated (at least one carbon-carbon triple bond), branched or unbranched, substituent consisting of carbon and hydrogen, for example, ethynyl, propargyl, butynyl, and pentynyl.

The term “alkynyloxy” means an alkynyl further consisting of a carbon-oxygen single bond, for example, pentynyloxy, hexynyloxy, heptynyloxy, and octynyloxy.

The term “aryl” means a cyclic, aromatic substituent consisting of hydrogen and carbon, for example, phenyl, naphthyl, and biphenyl.

The term “biopesticide” means a microbial biological pest control agent that, in general, is applied in a similar manner to chemical pesticides. Commonly they are bacterial, but there are also examples of fungal control agents, including Trichoderma spp. and Ampelomyces quisqualis. One well-known biopesticide example is Bacillus species, a bacterial disease of Lepidoptera, Coleoptera, and Diptera. Biopesticides include products based on entomopathogenic fungi (e.g. Metarhizium anisopliae), entomopathogenic nematodes (e.g. Steinernema feltiae), and entomopathogenic viruses (e.g. Cydia pomonella granulovirus). Other examples of entomopathogenic organisms include, but are not limited to, baculoviruses, protozoa, and Microsporidia. For the avoidance of doubt, biopesticides are active ingredients.

The term “cycloalkenyl” means a monocyclic or polycyclic, unsaturated (at least one carbon-carbon double bond) substituent consisting of carbon and hydrogen, for example, cyclobutenyl, cyclopentenyl, cyclohexenyl, norbornenyl, bicyclo[2.2.2]octenyl, tetrahydronaphthyl (tetralin), hexahydronaphthyl, and octahydronaphthyl.

The term “cycloalkenyloxy” means a cycloalkenyl further consisting of a carbon-oxygen single bond, for example, cyclobutenyloxy, cyclopentenyloxy, norbornenyloxy, and bicyclo[2.2.2]octenyloxy.

The term “cycloalkyl” means a monocyclic or polycyclic, saturated substituent consisting of carbon and hydrogen, for example, cyclopropyl, cyclobutyl, cyclopentyl, norbornyl, bicyclo[2.2.2]octyl, and decahydronaphthyl.

The term “cycloalkoxy” means a cycloalkyl further consisting of a carbon-oxygen single bond, for example, cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, norbornyloxy, and bicyclo[2.2.2]octyloxy.

The term “halo” means fluoro, chloro, bromo, and iodo.

The term “haloalkoxy” means an alkoxy further consisting of, from one to the maximum possible number of identical or different, halos, for example, fluoromethoxy, trifluoromethoxy, 2,2-difluoropropoxy, chloromethoxy, trichloromethoxy, 1,1,2,2-tetrafluoroethoxy, and pentafluoroethoxy.

The term “haloalkyl” means an alkyl further consisting of, from one to the maximum possible number of, identical or different, halos, for example, fluoromethyl, trifluoromethyl, 2,2-difluoropropyl, chloromethyl, trichloromethyl, and 1,1,2,2-tetrafluoroethyl.

The term “heterocyclyl” means a cyclic substituent that may be aromatic, fully saturated, or partially or fully unsaturated, where the cyclic structure contains at least one carbon and at least one heteroatom, where said heteroatom is nitrogen, sulfur, or oxygen. Examples are:

-   -   (1) aromatic heterocyclyl substituents include, but are not         limited to, benzofuranyl, benzoisothiazolyl, benzoisoxazolyl,         benzothienyl, benzothiazolyl, benzoxazolyl, cinnolinyl, furanyl,         imidazolyl, indazolyl, indolyl, isoindolyl, isoquinolinyl,         isothiazolyl, isoxazolyl, oxadiazolyl, oxazolinyl, oxazolyl,         phthalazinyl, pyrazinyl, pyrazolinyl, pyrazolyl, pyridazinyl,         pyridyl, pyrimidinyl, pyrrolyl, quinazolinyl, quinolinyl,         quinoxalinyl, tetrazolyl, thiazolinyl, thiazolyl, thienyl,         triazinyl, and triazolyl;     -   (2) fully saturated heterocyclyl substituents include, but are         not limited to, piperazinyl, piperidinyl, morpholinyl,         pyrrolidinyl, tetrahydrofuranyl, and tetrahydropyranyl;     -   (3) partially or fully unsaturated heterocyclyl substituents         include, but are not limited to, 4,5-dihydro-isoxazolyl,         4,5-dihydro-oxazolyl, 4,5-dihydro-1H-pyrazolyl,         2,3-dihydro-[1,3,4]-oxadiazolyl, and         1,2,3,4-tetrahydro-quinolinyl; and     -   (4) Additional examples of heterocyclyls include the following:

The term “locus” means a habitat, breeding ground, plant, seed, soil, material, or environment, in which a pest is growing, may grow, or may traverse. For example, a locus may be: where crops, trees, fruits, cereals, fodder species, vines, turf, and/or ornamental plants, are growing; where domesticated animals are residing; the interior or exterior surfaces of buildings (such as places where grains are stored); the materials of construction used in buildings (such as impregnated wood); and the soil around buildings.

The phrase “MoA Material” means an active ingredient having a mode of action (“MoA”) as indicated in IRAC MoA Classification v. 7.4, located at irac-online.org., which describes the following groups. One or more of these MoA Materials or active ingredients can be used in combination of the compounds of the invention.

(1) Acetylcholinesterase (AChE) inhibitors, includes the following active ingredients acephate, alanycarb, aldicarb, azamethiphos, azinphos-ethyl, azinphos-methyl, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, cadusafos, carbaryl, carbofuran, carbosulfan, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethiofencarb, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenobucarb, fenthion, formetanate, fosthiazate, furathiocarb, heptenophos, imicyafos, isofenphos, isoprocarb, isopropyl O-(methoxyaminothio-phosphoryl)salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, methiocarb, methomyl, metolcarb, mevinphos, monocrotophos, Naled, omethoate, oxamyl, oxydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimicarb, pirimiphos-methyl, profenofos, propetamphos, propoxur, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiodicarb, thiofanox, thiometon, triazamate, triazophos, trichlorfon, trimethacarb, vamidothion, XMC, and xylylcarb.

(2) GABA-gated chloride channel antagonists, includes the following active ingredients chlordane, endosulfan, ethiprole, and fipronil.

(3) Sodium channel modulators, includes the following active ingredients acrinathrin, allethrin, d-cis-trans-allethrin, d-trans-allethrin, bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans-isomers], deltamethrin, empenthrin [(EZ)-(1R)-isomers], esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, permethrin, phenothrin [(1R)-trans-isomer], prallethrin, pyrethrins (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R)-isomers], tralomethrin, and transfluthrin, and methoxychlor.

(4) Nicotinic acetylcholine receptor (nAChR) agonists, includes the following active ingredients

-   -   (4A) acetamiprid, clothianidin, dinotefuran, imidacloprid,         nitenpyram, thiacloprid, thiamethoxam,     -   (4B) nicotine,     -   (4C) sulfoxaflor,     -   (4D) flupyradifurone,     -   (4E) triflumezopyrim and dicloromezotiaz.

(5) Nicotinic acetylcholine receptor (nAChR) allosteric activators, includes the following active ingredients spinetoram and spinosad.

(6) Chloride channel activators, includes the following active ingredients abamectin, emamectin benzoate, lepimectin, and milbemectin.

(7) Juvenile hormone mimics, includes the following active ingredients hydroprene, kinoprene, methoprene, fenoxycarb, and pyriproxyfen.

(8) Miscellaneous nonspecific (multi-site) inhibitors, includes the following active ingredients methyl bromide, chloropicrin, sulfuryl fluoride, borax, boric acid, disodium octaborate, sodium borate, sodium metaborate, tartar emetic, diazomet, and metam.

(9) Modulators of Chordotonal Organs, includes the following active ingredients pymetrozine and flonicamid.

(10) Mite growth inhibitors, includes the following active ingredients clofentezine, hexythiazox, diflovidazin, and etoxazole.

(11) Microbial disruptors of insect midgut membranes, includes the following active ingredients Bacillus thuringiensis subsp. israelensis, Bacillus thuringiensis subsp. aizawai, Bacillus thuringiensis subsp. kurstaki, Bacillus thuringiensis subsp. tenebrionenis, Bt crop proteins (Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1/Cry35Ab1), and Bacillus sphaericus.

(12) Inhibitors of mitochondrial ATP synthase, includes the following active ingredients tetradifon, propargite, azocyclotin, cyhexatin, fenbutatin oxide, and diafenthiuron.

(13) Uncouplers of oxidative phosphorylation via disruption of the proton gradient, includes the following active ingredients chlorfenapyr, DNOC, and sulfluramid.

(14) Nicotinic acetylcholine receptor (nAChR) channel blockers, includes the following active ingredients bensultap, cartap hydrochloride, thiocyclam, and thiosultap-sodium.

(15) Inhibitors of chitin biosynthesis, type 0, includes the following active ingredients bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, and triflumuron.

(16) Inhibitors of chitin biosynthesis, type 1, includes the following active ingredient buprofezin.

(17) Moulting disruptor, Dipteran, includes the following active ingredient cyromazine.

(18) Ecdysone receptor agonists, includes the following active ingredients chromafenozide, halofenozide, methoxyfenozide, and tebufenozide.

(19) Octopamine receptor agonists, includes the following active ingredient amitraz.

(20) Mitochondrial complex III electron transport inhibitors, includes the following active ingredients hydramethylnon, acequinocyl, and fluacrypyrim.

(21) Mitochondrial complex I electron transport inhibitors, includes the following active ingredients fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad, and rotenone.

(22) Voltage-dependent sodium channel blockers, includes the following active ingredients indoxacarb and metaflumizone.

(23) Inhibitors of acetyl CoA carboxylase, includes the following active ingredients spirodiclofen, spiromesifen, and spirotetramat.

(24) Mitochondrial complex IV electron transport inhibitors, includes the following active ingredients, aluminium phosphide, calcium phosphide, phosphine, zinc phosphide, and cyanide.

(25) Mitochondrial complex II electron transport inhibitors, includes the following active ingredients cyenopyrafen, cyflumetofen, and pyflubumide, and

(28) Ryanodine receptor modulators, includes the following active ingredients chlorantraniliprole, cyantraniliprole, and flubendiamide.

Groups 26 and 27 are unassigned in this version of the classification scheme. Additionally, there is a Group UN that contains active ingredients of unknown or uncertain mode of action. This group includes the following active ingredients, azadirachtin, benzoximate, bifenazate, bromopropylate, chinomethionat, cryolite, dicofol, pyridalyl, and pyrifluquinazon.

The term “pest” means an organism that is detrimental to humans, or human concerns (such as, crops, food, livestock, etc.), where said organism is from Phyla Arthropoda, Mollusca, or Nematoda. Particular examples are ants, aphids, bed bugs, beetles, bristletails, caterpillars, cockroaches, crickets, earwigs, fleas, flies, grasshoppers, grubs, hornets, jassids, leafhoppers, lice, locusts, maggots, mealybugs, mites, moths, nematodes, plantbugs, planthoppers, psyllids, sawflies, scales, silverfish, slugs, snails, spiders, springtails, stink bugs, symphylans, termites, thrips, ticks, wasps, whiteflies, and wireworms.

Additional examples are pests in

(1) Subphyla Chelicerata, Myriapoda, and Hexapoda.

(2) Classes of Arachnida, Symphyla, and Insecta.

(3) Order Anoplura. A non-exhaustive list of particular genera includes, but is not limited to, Haematopinus spp., Hoplopleura spp., Linognathus spp., Pediculus spp., Polyplax spp., Solenopotes spp., and Neohaematopinis spp. A non-exhaustive list of particular species includes, but is not limited to, Haematopinus asini, Haematopinus suis, Linognathus setosus, Linognathus ovillus, Pediculus humanus capitis, Pediculus humanus humanus, and Pthirus pubis.

(4) Order Coleoptera. A non-exhaustive list of particular genera includes, but is not limited to, Acanthoscelides spp., Agriotes spp., Anthonomus spp., Apion spp., Apogonia spp., Araecerus spp., Aulacophora spp., Bruchus spp., Cerosterna spp., Cerotoma spp., Ceutorhynchus spp., Chaetocnema spp., Colaspis spp., Ctenicera spp., Curculio spp., Cyclocephala spp., Diabrotica spp., Dinoderus spp., Gnathocerus spp., Hemicoelus spp., Heterobostruchus spp., Hypera spp., Ips spp., Lyctus spp., Megascelis spp., Meligethes spp., Mezium spp., Niptus spp., Otiorhynchus spp., Pantomorus spp., Phyllophaga spp., Phyllotreta spp., Ptinus spp., Rhizotrogus spp., Rhynchites spp., Rhynchophorus spp., Scolytus spp., Sphenophorus spp., Sitophilus spp., Tenebrio spp., and Tribolium spp. A non-exhaustive list of particular species includes, but is not limited to, Acanthoscelides obtectus, Agrilus planipennis, Ahasverus advena, Alphitobius diaperinus, Anoplophora glabripennis, Anthonomus grandis, Anthrenus verbasci, Anthrenus falvipes, Ataenius spretulus, Atomaria linearis, Attagenus unicolor, Bothynoderes punctiventris, Bruchus pisorum, Callosobruchus maculatus, Carpophilus hemipterus, Cassida vittata, Cathartus quadricollis, Cerotoma trifurcata, Ceutorhynchus assimilis, Ceutorhynchus napi, Conoderus scalaris, Conoderus stigmosus, Conotrachelus nenuphar, Cotinis nitida, Crioceris asparagi, Cryptolestes ferrugineus, Cryptolestes pusillus, Cryptolestes turcicus, Cylindrocopturus adspersus, Deporaus marginatus, Dermestes lardarius, Dermestes maculatus, Epilachna varivestis, Euvrilletta peltata, Faustinus cubae, Hylobius pales, Hylotrupes bajulus, Hypera postica, Hypothenemus hampei, Lasioderma serricorne, Leptinotarsa decemlineata, Limonius canus, Liogenys fuscus, Liogenys suturalis, Lissorhoptrus oryzophilus, Lophocateres pusillus, Lyctus planicollis, Maecolaspis joliveti, Melanotus communis, Meligethes aeneus, Melolontha melolontha, Necrobia rufipes, Oberea brevis, Oberea linearis, Oryctes rhinoceros, Oryzaephilus mercator, Oryzaephilus surinamensis, Oulema melanopus, Oulema oryzae, Phyllophaga cuyabana, Polycaon stoutti, Popillia japonica, Prostephanus truncatus, Rhyzopertha dominica, Sitona lineatus, Sitophilus granarius, Sitophilus oryzae, Sitophilus zeamais, Stegobium paniceum, Tenebroides mauritanicus, Tribolium castaneum, Tribolium confusum, Trogoderma granarium, Trogoderma variabile, Xestobium rufovillosum, and Zabrus tenebrioides.

(5) Order Dermaptera. A non-exhaustive list of particular species includes, but is not limited to, Forficula auricularia.

(6) Order Blattaria. A non-exhaustive list of particular species includes, but is not limited to, Blattella germanica, Blattella asahinai, Blatta orientalis, Blatta lateralis, Parcoblatta pennsylvanica, Periplaneta americana, Periplaneta australasiae, Periplaneta brunnea, Periplaneta fuliginosa, Pycnoscelus surinamensis, and Supella longipalpa.

(7) Order Diptera. A non-exhaustive list of particular genera includes, but is not limited to, Aedes spp., Agromyza spp., Anastrepha spp., Anopheles spp., Bactrocera spp., Ceratitis spp., Chrysops spp., Cochliomyia spp., Contarinia spp., Culex spp., Culicoides spp., Dasineura spp., Delia spp., Drosophila spp., Fannia spp., Hylemya spp., Liriomyza spp., Musca spp., Phorbia spp., Pollenia spp., Psychoda spp., Simulium spp., Tabanus spp., and Tipula spp. A non-exhaustive list of particular species includes, but is not limited to, Agromyza frontella, Anastrepha suspensa, Anastrepha ludens, Anastrepha obliqua, Bactrocera cucurbitae, Bactrocera dorsalis, Bactrocera invadens, Bactrocera zonata, Ceratitis capitata, Dasineura brassicae, Delia platura, Fannia canicularis, Fannia scalaris, Gasterophilus intestinalis, Gracillia perseae, Haematobia irritans, Hypoderma lineatum, Liriomyza brassicae, Liriomyza sativa, Melophagus ovinus, Musca autumnalis, Musca domestica, Oestrus ovis, Oscinella frit, Pegomya betae, Piophila casei, Psila rosae, Rhagoletis cerasi, Rhagoletis pomonella, Rhagoletis mendax, Sitodiplosis mosellana, and Stomoxys calcitrans.

(8) Order Hemiptera. A non-exhaustive list of particular genera includes, but is not limited to, Adelges spp., Aulacaspis spp., Aphrophora spp., Aphis spp., Bemisia spp., Ceroplastes spp., Chionaspis spp., Chrysomphalus spp., Coccus spp., Empoasca spp., Euschistus spp., Lepidosaphes spp., Lagynotomus spp., Lygus spp., Macrosiphum spp., Nephotettix spp., Nezara spp., Nilaparvata spp., Philaenus spp., Phytocoris spp., Piezodorus spp., Planococcus spp., Pseudococcus spp., Rhopalosiphum spp., Saissetia spp., Therioaphis spp., Toumeyella spp., Toxoptera spp., Trialeurodes spp., Triatoma spp., and Unaspis spp. A non-exhaustive list of particular species includes, but is not limited to, Acrosternum hilare, Acyrthosiphon pisum, Aleyrodes proletella, Aleurodicus dispersus, Aleurothrixus floccosus, Amrasca biguttula biguttula, Aonidiella aurantii, Aphis fabae, Aphis gossypii, Aphis glycines, Aphis pomi, Aulacorthum solani, Bactericera cockerelli, Bagrada hilaris, Bemisia argentifolii, Bemisia tabaci, Blissus leucopterus, Boisea trivittata, Brachycorynella asparagi, Brevennia rehi, Brevicoryne brassicae, Cacopsylla pyri, Cacopsylla pyricola, Calocoris norvegicus, Ceroplastes rubens, Cimex hemipterus, Cimex lectularius, Coccus pseudomagnoliarum, Dagbertus fasciatus, Dichelops furcatus, Diuraphis noxia, Diaphorina citri, Dysaphis plantaginea, Dysdercus suturellus, Edessa meditabunda, Empoasca vitis, Eriosoma lanigerum, Erythroneura elegantula, Eurygaster maura, Euschistus conspersus, Euschistus heros, Euschistus servus, Halyomorpha halys, Helopeltis antonii, Hyalopterus pruni, Helopeltis antonii, Helopeltis theivora, Icerya purchasi, Idioscopus nitidulus, Jacobiasca formosana, Laodelphax striatellus, Lecanium corni, Leptocorisa oratorius, Leptocorisa varicornis, Lygus hesperus, Maconellicoccus hirsutus, Macrosiphum euphorbiae, Macrosiphum granarium, Macrosiphum rosae, Macrosteles quadrilineatus, Mahanarva frimbiolata, Megacopta cribraria, Metopolophium dirhodum, Mictis longicornis, Myzus persicae, Nasonovia ribisnigri, Nephotettix cincticeps, Neurocolpus longirostris, Nezara viridula, Nilaparvata lugens, Paracoccus marginatus, Paratrioza cockerelli, Parlatoria pergandii, Parlatoria ziziphi, Peregrinus maidis, Phylloxera vitifoliae, Physokermes piceae, Phytocoris californicus, Phytocoris relativus, Piezodorus guildinii, Planococcus citri, Planococcus ficus, Poecilocapsus lineatus, Psallus vaccinicola, Pseudacysta perseae, Pseudococcus brevipes, Quadraspidiotus perniciosus, Rhopalosiphum maidis, Rhopalosiphum padi, Saissetia oleae, Scaptocoris castanea, Schizaphis graminum, Sitobion avenae, Sogatella furcifera, Trialeurodes vaporariorum, Trialeurodes abutiloneus, Unaspis yanonensis, and Zulia entrerriana.

-   -   (9) Order Hymenoptera. A non-exhaustive list of particular         genera includes, but is not limited to, Acromyrmex spp., Atta         spp., Camponotus spp., Diprion spp., Dolichovespula spp.,         Formica spp., Monomorium spp., Neodiprion spp., Paratrechina         spp., Pheidole spp., Pogonomyrmex spp., Polistes spp.,         Solenopsis spp., Technomyrmex, spp., Tetramorium spp., Vespula         spp., Vespa spp., and Xylocopa spp. A non-exhaustive list of         particular species includes, but is not limited to, Athalia         rosae, Atta texana, Caliroa cerasi, Cimbex americana,         Iridomyrmex humilis, Linepithema humile, Mellifera Scutellata,         Monomorium minimum, Monomorium pharaonis, Neodiprion sertifer,         Solenopsis invicta, Solenopsis geminata, Solenopsis molesta,         Solenopsis richtery, Solenopsis xyloni, Tapinoma sessile, and         Wasmannia auropunctata.

(10) Order Isoptera. A non-exhaustive list of particular genera includes, but is not limited to, Coptotermes spp., Cornitermes spp., Cryptotermes spp., Heterotermes spp., Kalotermes spp., Incisitermes spp., Macrotermes spp., Marginitermes spp., Microcerotermes spp., Procornitermes spp., Reticulitermes spp., Schedorhinotermes spp., and Zootermopsis spp. A non-exhaustive list of particular species includes, but is not limited to, Coptotermes acinaciformis, Coptotermes curvignathus, Coptotermes frenchi, Coptotermes formosanus, Coptotermes gestroi, Cryptotermes brevis, Heterotermes aureus, Heterotermes tenuis, Incisitermes minor, Incisitermes snyderi, Microtermes obesi, Nasutitermes corniger, Odontotermes formosanus, Odontotermes obesus, Reticulitermes banyulensis, Reticulitermes grassei, Reticulitermes flavipes, Reticulitermes hageni, Reticulitermes hesperus, Reticulitermes santonensis, Reticulitermes speratus, Reticulitermes tibialis, and Reticulitermes virginicus.

(11) Order Lepidoptera. A non-exhaustive list of particular genera includes, but is not limited to, Adoxophyes spp., Agrotis spp., Argyrotaenia spp., Cacoecia spp., Caloptilia spp., Chilo spp., Chrysodeixis spp., Colias spp., Crambus spp., Diaphania spp., Diatraea spp., Earias spp., Ephestia spp., Epimecis spp., Feltia spp., Gortyna spp., Helicoverpa spp., Heliothis spp., Indarbela spp., Lithocolletis spp., Loxagrotis spp., Malacosoma spp., Nemapogon spp., Peridroma spp., Phyllonorycter spp., Pseudaletia spp., Plutella spp., Sesamia spp., Spodoptera spp., Synanthedon spp., and Yponomeuta spp. A non-exhaustive list of particular species includes, but is not limited to, Achaea janata, Adoxophyes orana, Agrotis ipsilon, Alabama argillacea, Amorbia cuneana, Amyelois transitella, Anacamptodes defectaria, Anarsia lineatella, Anomis sabulifera, Anticarsia gemmatalis, Archips argyrospila, Archips rosana, Argyrotaenia citrana, Autographa gamma, Bonagota cranaodes, Borbo cinnara, Bucculatrix thurberiella, Capua reticulana, Carposina niponensis, Chlumetia transversa, Choristoneura rosaceana, Cnaphalocrocis medinalis, Conopomorpha cramerella, Corcyra cephalonica, Cossus cossus, Cydia caryana, Cydia funebrana, Cydia molesta, Cydia nigricana, Cydia pomonella, Darna diducta, Diaphania nitidalis, Diatraea saccharalis, Diatraea grandiosella, Earias insulana, Earias vittella, Ecdytolopha aurantianum, Elasmopalpus lignosellus, Ephestia cautella, Ephestia elutella, Ephestia kuehniella, Epinotia aporema, Epiphyas postvittana, Erionota thrax, Estigmene acrea, Eupoecilia ambiguella, Euxoa auxiliaris, Galleria mellonella, Grapholita molesta, Hedylepta indicata, Helicoverpa armigera, Helicoverpa zea, Heliothis virescens, Hellula undalis, Keiferia lycopersicella, Leucinodes orbonalis, Leucoptera coffeella, Leucoptera malifoliella, Lobesia botrana, Loxagrotis albicosta, Lymantria dispar, Lyonetia clerkella, Mahasena corbetti, Mamestra brassicae, Manduca sexta, Maruca testulalis, Metisa plana, Mythimna unipuncta, Neoleucinodes elegantalis, Nymphula depunctalis, Operophtera brumata, Ostrinia nubilalis, Oxydia vesulia, Pandemis cerasana, Pandemis heparana, Papilio demodocus, Pectinophora gossypiella, Peridroma saucia, Perileucoptera coffeella, Phthorimaea operculella, Phyllocnistis citrella, Phyllonorycter blancardella, Pieris rapae, Plathypena scabra, Platynota idaeusalis, Plodia interpunctella, Plutella xylostella, Polychrosis viteana, Prays endocarpa, Prays oleae, Pseudaletia unipuncta, Pseudoplusia includens, Rachiplusia nu, Scirpophaga incertulas, Sesamia inferens, Sesamia nonagrioides, Setora nitens, Sitotroga cerealella, Sparganothis pilleriana, Spodoptera exigua, Spodoptera frugiperda, Spodoptera eridania, Thecla basilides, Tinea pellionella, Tineola bisselliella, Trichoplusia ni, Tuta absoluta, Zeuzera coffeae, and Zeuzea pyrina.

(12) Order Mallophaga. A non-exhaustive list of particular genera includes, but is not limited to, Anaticola spp., Bovicola spp., Chelopistes spp., Goniodes spp., Menacanthus spp., and Trichodectes spp. A non-exhaustive list of particular species includes, but is not limited to, Bovicola bovis, Bovicola caprae, Bovicola ovis, Chelopistes meleagridis, Goniodes dissimilis, Goniodes gigas, Menacanthus stramineus, Menopon gallinae, and Trichodectes canis.

(13) Order Orthoptera. A non-exhaustive list of particular genera includes, but is not limited to, Melanoplus spp. and Pterophylla spp. A non-exhaustive list of particular species includes, but is not limited to, Acheta domesticus, Anabrus simplex, Gryllotalpa africana, Gryllotalpa australis, Gryllotalpa brachyptera, Gryllotalpa hexadactyla, Locusta migratoria, Microcentrum retinerve, Schistocerca gregaria, and Scudderia furcata.

(14) Order Psocoptera. A non-exhaustive list of particular species includes, but is not limited to, Liposcelis decolor, Liposcelis entomophila, Lachesilla quercus, and Trogium pulsatorium.

(15) Order Siphonaptera. A non-exhaustive list of particular species includes, but is not limited to, Ceratophyus gallinae, Ceratophyus niger, Ctenocephalides canis, Ctenocephalides felis, and Pulex irritans.

(16) Order Thysanoptera. A non-exhaustive list of particular genera includes, but is not limited to, Caliothrips spp., Frankliniella spp., Scirtothrips spp., and Thrips spp. A non-exhaustive list of particular species includes, but is not limited to, Caliothrips phaseoli, Frankliniella bispinosa, Frankliniella fusca, Frankliniella occidentalis, Frankliniella schultzei, Frankliniella tritici, Frankliniella williamsi, Heliothrips haemorrhoidalis, Rhipiphorothrips cruentatus, Scirtothrips citri, Scirtothrips dorsalis, Taeniothrips rhopalantennalis, Thrips hawaiiensis, Thrips nigropilosus, Thrips orientalis, Thrips palmi, and Thrips tabaci.

(17) Order Thysanura. A non-exhaustive list of particular genera includes, but is not limited to, Lepisma spp. and Thermobia spp.

(18) Order Acarina. A non-exhaustive list of particular genera includes, but is not limited to, Acarus spp., Aculops spp., Argus spp., Boophilus spp., Demodex spp., Dermacentor spp., Epitrimerus spp., Eriophyes spp., Ixodes spp., Oligonychus spp., Panonychus spp., Rhizoglyphus spp., and Tetranychus spp. A non-exhaustive list of particular species includes, but is not limited to, Acarapis woodi, Acarus siro, Aceria mangiferae, Aculops lycopersici, Aculus pelekassi, Aculus schlechtendali, Amblyomma americanum, Brevipalpus obovatus, Brevipalpus phoenicis, Dermacentor variabilis, Dermatophagoides pteronyssinus, Eotetranychus carpini, Liponyssoides sanguineus, Notoedres cati, Oligonychus coffeae, Oligonychus ilicis, Ornithonyssus bacoti, Panonychus citri, Panonychus ulmi, Phyllocoptruta oleivora, Polyphagotarsonemus latus, Rhipicephalus sanguineus, Sarcoptes scabiei, Tegolophus perseaflorae, Tetranychus urticae, Tyrophagus longior, and Varroa destructor.

(19) Order Araneae. A non-exhaustive list of particular genera includes, but is not limited to, Loxosceles spp., Latrodectus spp., and Atrax spp. A non-exhaustive list of particular species includes, but is not limited to, Loxosceles reclusa, Latrodectus mactans, and Atrax robustus.

(20) Class Symphyla. A non-exhaustive list of particular species includes, but is not limited to, Scutigerella immaculata.

(21) Subclass Collembola. A non-exhaustive list of particular species includes, but is not limited to, Bourletiella hortensis, Onychiurus armatus, Onychiurus fimetarius, and Sminthurus viridis.

(22) Phylum Nematoda. A non-exhaustive list of particular genera includes, but is not limited to, Aphelenchoides spp., Belonolaimus spp., Criconemella spp., Ditylenchus spp., Globodera spp., Heterodera spp., Hirschmanniella spp., Hoplolaimus spp., Meloidogyne spp., Pratylenchus spp., and Radopholus spp. A non-exhaustive list of particular species includes, but is not limited to, Dirofilaria immitis, Globodera pallida, Heterodera glycines, Heterodera zeae, Meloidogyne incognita, Meloidogyne javanica, Onchocerca volvulus, Pratylenchus penetrans, Radopholus similis, and Rotylenchulus reniformis.

(23) Phylum Mollusca. A non-exhaustive list of particular species includes, but is not limited to, Arion vulgaris, Cornu aspersum, Deroceras reticulatum, Limax flavus, Milax gagates, and Pomacea canaliculata.

A particularly preferred pest group to control is sap-feeding pests. Sap-feeding pests, in general, have piercing and/or sucking mouthparts and feed on the sap and inner plant tissues of plants. Examples of sap-feeding pests of particular concern to agriculture include, but are not limited to, aphids, leafhoppers, moths, scales, thrips, psyllids, mealybugs, stinkbugs, and whiteflies. Specific examples of Orders that have sap-feeding pests of concern in agriculture include but are not limited to, Anoplura and Hemiptera. Specific examples of Hemiptera that are of concern in agriculture include, but are not limited to, Aulacaspis spp., Aphrophora spp., Aphis spp., Bemisia spp., Coccus spp., Euschistus spp., Lygus spp., Macrosiphum spp., Nezara spp., and Rhopalosiphum spp.

Another particularly preferred pest group to control is chewing pests. Chewing pests, in general, have mouthparts that allow them to chew on the plant tissue including roots, stems, leaves, buds, and reproductive tissues (including, but not limited to flowers, fruit, and seeds). Examples of chewing pests of particular concern to agriculture include, but are not limited to, caterpillars, beetles, grasshoppers, and locusts. Specific examples of Orders that have chewing pests of concern in agriculture include but are not limited to, Coleoptera and Lepidoptera. Specific examples of Coleoptera that are of concern in agriculture include, but are not limited to, Anthonomus spp., Cerotoma spp., Chaetocnema spp., Colaspis spp., Cyclocephala spp., Diabrotica spp., Hypera spp., Phyllophaga spp., Phyllotreta spp., Sphenophorus spp., Sitophilus spp.

The phrase “pesticidally effective amount” means the amount of a pesticide needed to achieve an observable effect on a pest, for example, the effects of necrosis, death, retardation, prevention, removal, destruction, or otherwise diminishing the occurrence and/or activity of a pest in a locus. This effect may come about when pest populations are repulsed from a locus, pests are incapacitated in, or around, a locus, and/or pests are exterminated in, or around, a locus. Of course, a combination of these effects can occur. Generally, pest populations, activity, or both are desirably reduced more than fifty percent, preferably more than 90 percent, and most preferably more than 99 percent. In general, a pesticidally effective amount, for agricultural purposes, is from about 0.0001 grams per hectare to about 5000 grams per hectare, preferably from about 0.0001 grams per hectare to about 500 grams per hectare, and it is even more preferably from about 0.0001 grams per hectare to about 50 grams per hectare.

DETAILED DESCRIPTION OF THIS DISCLOSURE

This document discloses molecules of Formula One

wherein:

-   -   (A) Ar¹ is selected from the group consisting of furanyl,         phenyl, pyridazinyl, pyridyl, pyrimidinyl, or thienyl,         -   wherein each furanyl, phenyl, pyridazinyl, pyridyl,             pyrimidinyl, and thienyl may be optionally substituted with             one or more substituents independently selected from the             group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl,             (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy,             (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl,             S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl,             OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkoxy,             haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy             substituent may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl,             (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy,             (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl,             S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl,             OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy;     -   (B) Het is a 5- or 6-membered, saturated or unsaturated,         heterocyclic ring, containing one or more heteroatoms         independently selected from nitrogen, sulfur, or oxygen, and         where Ar¹ and Ar² are not ortho to each other, but may be meta         or para, for example, for a five-membered ring they are 1,3, and         for a 6-membered ring they are either 1,3 or 1,4,         -   wherein each heterocyclic ring may be optionally substituted             with one or more substituents independently selected from             the group consisting of H, F, Cl, Br, I, CN, NO₂, oxo,             (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl,             (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl,             S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl,             OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₆₈alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkoxy,             haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy             substituent may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl,             (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy,             (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl,             S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl,             OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy;     -   (C) L¹ is selected from the group consisting of O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, O—(C₁-C₈)haloalkyl,         O—(C₃-C₈)cycloalkyl, O—(C₁-C₈)haloalkoxy, O—(C₂-C₈)alkenyl, and         O—(C₂-C₈)alkynyl,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkenyl, and             alkynyl may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl,             (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy,             (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, and (C₂-C₈)alkynyl;     -   (D) Ar² is selected from the group consisting of furanyl,         phenyl, pyridazinyl, pyridyl, pyrimidinyl, or thienyl, and where         Het and L are not ortho to each other, but may be meta or para,         for example, for a five-membered ring they are 1,3, and for a         6-membered ring they are either 1,3 or 1,4,         -   wherein each furanyl, phenyl, pyridazinyl, pyridyl,             pyrimidinyl, and thienyl may be optionally substituted with             one or more substituents independently selected from the             group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y),             (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl,             (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl,             S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkoxy,             haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy             substituent may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl,             (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy,             (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl,             S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl,             OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy;     -   (E) R¹⁵ is selected from the group consisting of H,         (C₁-C₈)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl,         S(O)_(n)—(C₁-C₈)alkyl, C(O)—NR^(x)R^(y), C(O)-phenyl,         (C₁-C₈)alkyl-NR^(x)R^(y), C(O)O—(C₁-C₈)alkyl,         C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl,         C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl,         (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)O—(C₁-C₈)alkyl,         -   wherein each alkyl, cycloalkyl, alkenyl, alkynyl, and phenyl             may be optionally substituted with one or more substituents             independently selected from the group consisting of H, F,             Cl, Br, I, CN, NO₂, oxo, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl,             (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy,             (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl,             S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl,             OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy;     -   (F) Q¹ is selected from the group consisting of O and S;     -   (G) Q² is selected from the group consisting of O and S;     -   (H) R¹⁶ is selected from the group consisting of (K), H,         (C₁-C₈)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl,         C(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, (C₁-C₈)alkylphenyl,         (C₁-C₈)alkyl-O-phenyl, C(O)-(Het-1), (Het-1),         (C₁-C₈)alkyl-(Het-1), (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)—NR^(x)R^(y),         (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-(Het-1),         (C₁-C₈)alkyl-C(O)-(Het-1),         (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl(NR^(x)R^(y))—C(O)OH,         (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-NR^(x)R^(y),         (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-N(R^(x))—C(O)O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl(N(R^(x))—C(O)O—(C₁-C₈)alkyl)-C(O)OH,         (C₁-C₈)alkyl-C(O)-(Het-1)-C(O)O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)—(C₃-C₈)cycloalkyl,         (C₁-C₈)alkyl-OC(O)-(Het-1),         (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl-N(R^(x))—C(O)O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-NR^(x)R^(y), (C₁-C₈)alkyl-S(O)_(n)-(Het-1), and         (C₁-C₈)alkyl-O-(Het-1),         -   wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl,             and (Het-1) may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y),             (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₈)alkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl,             S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl,             OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)OH,             C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y),             C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl,             C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl,             C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl,             (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl), phenyl, phenoxy,             Si((C₁-C₈)alkyl)₃, S(O)_(n)—NR^(x)R^(y), and (Het-1);     -   (I) R¹⁷ is selected from the group consisting of (K), H,         (C₁-C₈)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl,         C(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, (C₁-C₈)alkylphenyl,         (C₁-C₈)alkyl-O-phenyl, C(O)-(Het-1), (Het-1),         (C₁-C₈)alkyl-(Het-1), (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)—NR^(x)R^(y),         (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-(Het-1),         (C₁-C₈)alkyl-C(O)-(Het-1),         (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl(NR^(x)R^(y))—C(O)OH,         (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-NR^(x)R^(y),         (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-N(R^(x))—C(O)O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl(N(R^(x))—C(O)O—(C₁-C₈)alkyl)-C(O)OH,         (C₁-C₈)alkyl-C(O)-(Het-1)-C(O)O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-OC(O)—(C₃-C₈)cycloalkyl,         (C₁-C₈)alkyl-OC(O)-(Het-1),         (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl-N(R^(x))—C(O)O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-NR^(x)R^(y), (C₁-C₈)alkyl-S(O)_(n)-(Het-1), and         (C₁-C₈)alkyl-O-(Het-1),         -   wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl,             and (Het-1) may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y),             (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl,             (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl,             S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl,             OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)OH, C(O)—NR^(x)R^(y),             (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, phenoxy,             Si((C₁-C₈)alkyl)₃, S(O)_(n)—NR^(x)R^(y), and (Het-1);     -   (J) L² is selected from the group consisting of         (C₃-C₈)cycloalkyl, phenyl, (C₃-C₁₂)cycloalkenyl (for example         tetrahydronaphthyl or tetralin), (C₁-C₈)alkylphenyl,         (C₁-C₈)alkyl-O-phenyl, (C₂-C₈)alkenyl-O-phenyl, (Het-1),         (C₁-C₈)alkyl-(Het-1), and (C₁-C₈)alkyl-O-(Het-1),         -   wherein each alkyl, cycloalkyl, alkenyl, phenyl, and (Het-1)             may be optionally substituted with one or more substituents             independently selected from the group consisting of H, F,             Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₈)alkyl,             (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy,             (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl,             S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl,             OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)H,             C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y),             C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl,             C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₁-C₈)cycloalkyl,             C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, O—(C₁-C₈)alkyl,             S—(C₁-C₈)alkyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, phenoxy, and             (Het-1);     -   (K) R¹⁶ and R¹⁷ along with C^(x)(Q²)(N^(x)), form a 4- to         7-membered saturated or unsaturated, heterocyclic ring, which         may further contain one or more heteroatoms selected from the         group consisting of nitrogen, sulfur, and oxygen,         -   wherein each heterocyclic ring may be optionally substituted             with one or more substituents independently selected from             the group consisting of oxo, R¹⁸, and R¹⁹,         -   wherein R¹⁸ and R¹⁹ are each independently selected from the             group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y),             oxo, thioxo, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl,             (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy,             (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl,             S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl,             OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and (Het-1);     -   (L) R^(x) and R^(y) are each independently selected from the         group consisting of H, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl,         (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy,         (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl,         S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl,         OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)—(C₁-C₈)alkyl,         C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,         C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,         C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,         C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,         (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,         C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, and phenyl,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkoxy,             haloalkoxy, alkenyl, alkynyl, and phenyl may be optionally             substituted with one or more substituents independently             selected from the group consisting of H, F, Cl, Br, I, CN,             NO₂, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl,             (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl,             S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl,             OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and (Het-1);     -   (M) (Het-1) is a 5- or 6-membered, saturated or unsaturated,         heterocyclic ring, containing one or more heteroatoms         independently selected from the group consisting of nitrogen,         sulfur, or oxygen,         -   wherein each heterocyclic ring may be optionally substituted             with one or more substituents independently selected from             the group consisting of H, F, Cl, Br, I, CN, NO₂, oxo,             (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl,             (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl,             S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl,             OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkoxy,             haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy             substituent may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl,             (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy,             (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl,             S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl,             OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl,             C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl,             C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl,             C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl,             (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl,             C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy;     -   (N) n are each independently 0, 1, or 2; and         N-oxides, agriculturally acceptable acid addition salts, salt         derivatives, solvates, crystal polymorphs, isotopes, resolved         stereoisomers, and tautomers, of the molecules of Formula One.

The molecules of Formula One may exist in different geometric or optical isomeric or different tautomeric forms. One or more centers of chirality may be present in which case molecules of Formula One may be present as pure enantiomers, mixtures of enantiomers, pure diastereomers or mixtures of diastereomers. It will be appreciated by those skilled in the art that one stereoisomer may be more active than the other stereoisomers. Individual stereoisomers may be obtained by known selective synthetic procedures, by conventional synthetic procedures using resolved starting materials, or by conventional resolution procedures. There may be double bonds present in the molecule, in which case compounds of Formula One may exist as single geometric isomers (cis or trans, E or Z) or mixtures of geometric isomers (cis and trans, E and Z). Centers of tautomerisation may be present. This disclosure covers all such isomers, tautomers, and mixtures thereof, in all proportions. The structures disclosed in the present disclosure are drawn in only one geometric form for clarity, but are intended to represent all geometric forms of the molecule.

In another embodiment Ar¹ is (1a)

-   -   wherein, R¹, R², R³, R⁴, and R⁵ are each independently selected         from the group consisting of H, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,         (C₁-C₆)alkoxy, and (C₁-C₆)haloalkoxy.

In another embodiment:

-   -   (1) R¹, R², R⁴, and R⁵ are each independently H; and     -   (2) R³ is (C₁-C₄)haloalkoxy.

This embodiment may be used in combination with the other embodiments of Het, L¹, Ar², R¹⁵, Q¹, Q², R¹⁶, R¹⁷, and L².

In another embodiment Ar¹ is (1a), wherein R³ is OCF₃. This embodiment may be used in combination with the other embodiments of R¹, R², R⁴, R⁵, Het, L¹, Ar², R¹⁵, Q¹, Q², R¹⁶, R¹⁷, and L².

In another embodiment Het is (1b)

-   -   wherein R⁶ is H. This embodiment may be used in combination with         the other embodiments of Ar¹, L¹, Ar², R¹⁵, Q¹, Q², R¹⁶, R¹⁷,         and L².

When L¹ has a terminal oxygen atom, the oxygen atom is linked to the Ar² group. For example, L¹ is —O—CH₂— as shown in Compound F1 listed in Table 1, where the oxygen atom is linked to the Ar² group.

In another embodiment L¹ is

-   -   wherein R⁷, R⁸, R⁹, and R¹⁰ are each independently selected from         the group consisting of H, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl,         (C₁-C₆)alkoxy and (C₁-C₆)haloalkoxy.

In another embodiment, R⁸ and R¹⁰ are each independently H. This embodiment may be used in combination with the other embodiments of Ar¹, Het, Ar², R¹⁵, Q¹, Q², R¹⁶, R¹⁷, and L².

In another embodiment Ar² is (1e)

-   -   wherein:         -   (1) X¹ is selected from the group consisting of N and CR¹³,         -   (2) X² is selected from the group consisting of N and CR¹⁴,             and         -   (3) R¹¹, R¹², R¹³, and R¹⁴ are each independently selected             from the group consisting of H, F, Cl, Br, I, CN, NO₂,             NR^(x)R^(y), (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, phenyl,             (C₁-C₆)alkoxy, and (C₁-C₆)haloalkoxy.

In another embodiment:

-   -   (1) R¹¹ and R¹² are each independently H or F;     -   (2) X¹ is N or CR¹³, wherein R¹³ is H, F, Cl, (C₁-C₄)alkyl, or         (C₁-C₄)alkoxy; and     -   (3) X² is N or CR¹⁴, wherein R¹⁴ is H, F, Cl, or (C₁-C₄)alkoxy.

This embodiment may be used in combination with the other embodiments of Ar¹, Het, L¹, R^(s1), Q¹, Q², R¹⁶, R¹⁷, and L².

In another embodiment Ar² is (1e), wherein R¹³ is CH₃ or OCH₃. This embodiment may be used in combination with the other embodiments of Ar¹, Het, L¹, R¹¹, R¹², X², Q¹, Q², R¹⁶, R¹⁷, and L².

In another embodiment Ar² is (1e), wherein R¹⁴ is OCH₃. This embodiment may be used in combination with the other embodiments of Ar¹, Het, L¹, R¹¹, R¹², X¹, Q¹, Q², R¹⁶, R¹⁷, and L².

In another embodiment R¹⁵ is H, (C₁-C₆)alkyl or (C₂-C₆)alkenyl, wherein said alkyl is optionally substituted with a (C₃-C₆)cycloalkyl or (C₁-C₆)alkoxy.

In another embodiment R¹⁵ is H. This embodiment may be used in combination with the other embodiments of Ar¹, Het, L¹, Ar², Q¹, Q², R¹⁶, R¹⁷, and L².

In another embodiment Q¹ is O. This embodiment may be used in combination with the other embodiments of Ar¹, Het, L¹, Ar², R¹⁵, Q², R¹⁶, R¹⁷, and L².

In another embodiment Q² is S. This embodiment may be used in combination with the other embodiments of Ar¹, Het, L¹, Ar², R¹⁵, Q¹, R¹⁶, R¹⁷, and L².

In another embodiment L² is (1f)

-   -   wherein, R²⁰, R²¹, R²², R²³, and R²⁴ are each independently         selected from the group consisting of H, F, Cl, Br, I, CN, NO₂,         NR^(x)R^(y), (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, phenyl,         (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, C(O)O—(C₁-C₆)alkyl,         (C₁-C₆)alkyl-O—(C₁-C₆)alkyl, (C₁-C₆)alkyl-S(O)_(n)—(C₁-C₆)alkyl,         (C₁-C₆)alkyl-S—(C₁-C₆)alkyl, and optionally R²⁰ and R²¹ together         form a (C₃-C₈)cycloalkyl.

In another embodiment:

-   -   (1) R²⁰ is F, (C₁-C₄)haloalkyl, (C₁-C₄)alkyl, (C₁-C₄)haloalkoxy,         (C₁-C₄)alkoxy, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-S—(C₁-C₄)alkyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, or         optionally R²⁰ and R²¹ together form a (C₃-C₈)cycloalkyl;     -   (2) R²¹ is H or optionally R²⁰ and R²¹ together form a         (C₃-C₈)cycloalkyl;     -   (3) R²² is H, F, C(O)O—(C₁-C₄)alkyl, or (C₁-C₄)alkoxy;     -   (4) R²³ is H, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, or (C₁-C₄)alkyl;         and     -   (5) R²⁴ is H or (C₁-C₄)alkyl.

This embodiment may be used in combination with the other embodiments of Ar¹, Het, L¹, Ar², R¹⁵, Q¹, Q², R¹⁶, and R¹⁷.

In another embodiment L² is (1f), wherein R²⁰ is CH₂CH₂CH₃, CH(CH₃)₂, CH₂OCH₃, CH(CH₃)SCH₃, or CH(CH₃)OCH₃. This embodiment may be used in combination with the other embodiments of Ar¹, Het, L¹, Ar², Q¹, Q², R¹⁶, R¹⁷, R²¹, R²², R²³, and R²⁴.

In another embodiment L² is (1f), wherein R²³ is CH₃. This embodiment may be used in combination with the other embodiments of Ar¹, Het, L¹, Ar², Q¹, Q², R¹⁶, R¹⁷, R²⁰, R²¹, R²², and R²⁴.

In another embodiment R¹⁶ and R¹⁷ along with C^(x)(Q²)(N^(x)), is (1g)

-   -   wherein R¹⁸ and R¹⁹ are each independently selected from the         group consisting of H, F, Cl, Br, I, CN, OH, NO₂, NR^(x)R^(y),         (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy,         (C₁-C₆)haloalkoxy, phenyl, and oxo.

In another embodiment, R¹⁸ and R¹⁹ are each independently H. This embodiment may be used in combination with the other embodiments of Ar¹, Het, L¹, Ar², R¹⁵, Q¹, and L².

In another embodiment.

-   -   (A) Ar¹ is (1a)

-   -   -   wherein, R¹, R², R³, R⁴, and R⁵ are each independently             selected from the group consisting of H, F, Cl, Br, I, CN,             NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl,             (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkoxy,             haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy may be             optionally substituted with one or more substituents             independently selected from the group consisting of H, F,             Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy;

    -   (B) Het is (1b)

-   -   -   wherein, R⁶ is selected from the group consisting of H, F,             Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkoxy,             haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy may be             optionally substituted with one or more substituents             independently selected from the group consisting of H, F,             Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy;

    -   (C) L¹ is

-   -   -   wherein R⁷, R⁸, R⁹, and R¹⁰ are each independently selected             from the group consisting of H, CN, NO₂, (C₁-C₄)alkyl,             (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, and (C₂-C₆)alkynyl;

    -   (D) Ar² is (1e)

-   -   -   wherein:         -   (1) X¹ is selected from the group consisting of N and CR¹³,         -   (2) X² is selected from the group consisting of N and CR¹⁴,             and         -   (3) R¹¹, R¹², R¹³, and R¹⁴ are each independently selected             from the group consisting of H, F, Cl, Br, I, CN, NO₂,             (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl,             (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkoxy,             haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy may be             optionally substituted with one or more substituents             independently selected from the group consisting of H, F,             Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy;

    -   (E) R¹⁵ is selected from the group consisting of H,         (C₁-C₄)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl,         S(O)_(n)—(C₁-C₄)alkyl, C(O)—NR^(x)R^(y), C(O)-phenyl,         (C₁-C₄)alkyl-NR^(x)R^(y), C(O)O—(C₁-C₄)alkyl,         C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl,         C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl,         (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)O—(C₁-C₄)alkyl,         -   wherein each alkyl, cycloalkyl, alkenyl, alkynyl, and phenyl             may be optionally substituted with one or more substituents             independently selected from the group consisting of H, F,             Cl, Br, I, CN, NO₂, oxo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy;

    -   (F) Q¹ is selected from the group consisting of O and S;

    -   (G) Q² is selected from the group consisting of O and S;

    -   (H) R¹⁶ is selected from the group consisting of (K), H,         (C₁-C₄)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl,         C(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, (C₁-C₄)alkylphenyl,         (C₁-C₄)alkyl-O-phenyl, C(O)-(Het-1), (Het-1),         (C₁-C₄)alkyl-(Het-1), (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)—NR^(x)R^(y),         (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-(Het-1),         (C₁-C₄)alkyl-C(O)-(Het-1),         (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl(NR^(x)R^(y))—C(O)OH,         (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-NR^(x)R^(y),         (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-N(R^(x))—C(O)O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl(N(R^(x))—C(O)O—(C₁-C₄)alkyl)-C(O)OH,         (C₁-C₄)alkyl-C(O)-(Het-1)-C(O)O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)—(C₃-C₈)cycloalkyl,         (C₁-C₄)alkyl-OC(O)-(Het-1),         (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl-N(R^(x))—C(O)O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-NR^(x)R^(y), (C₁-C₄)alkyl-S(O)_(n)-(Het-1), and         (C₁-C₄)alkyl-O-(Het-1),         -   wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl,             and (Het-1) may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y),             (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₄)alkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl,             S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl,             OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)OH,             C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y),             C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl,             C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl,             C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl,             (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl), phenyl, phenoxy,             Si((C₁-C₄)alkyl)₃, S(O)_(n)—NR^(x)R^(y), and (Het-1);

    -   (I) R¹⁷ is selected from the group consisting of (K), H,         (C₁-C₄)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl,         C(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, (C₁-C₄)alkylphenyl,         (C₁-C₄)alkyl-O-phenyl, C(O)-(Het-1), (Het-1),         (C₁-C₄)alkyl-(Het-1), (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)—NR^(x)R^(y),         (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-(Het-1),         (C₁-C₄)alkyl-C(O)-(Het-1),         (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl(NR^(x)R^(y))—C(O)OH,         (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-NR^(x)R^(y),         (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-N(R^(x))—C(O)O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl(N(R^(x))—C(O)O—(C₁-C₄)alkyl)-C(O)OH,         (C₁-C₄)alkyl-C(O)-(Het-1)-C(O)O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-OC(O)—(C₃-C₈)cycloalkyl,         (C₁-C₄)alkyl-OC(O)-(Het-1),         (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl-N(R^(x))—C(O)O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-NR^(x)R^(y), (C₁-C₄)alkyl-S(O)_(n)-(Het-1), and         (C₁-C₄)alkyl-O-(Het-1),         -   wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl,             and (Het-1) may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y),             (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₄)alkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl,             S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl,             OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)OH,             C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y),             C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl,             C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl,             C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl,             (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, phenoxy,             Si((C₁-C₄)alkyl)₃, S(O)_(n)—NR^(x)R^(y), and (Het-1);

    -   (J) L² is (1f)

-   -   -   wherein, R²⁰, R²¹, R²², R²³, and R²⁴ are each independently             selected from the group consisting of H, F, Cl, Br, I, CN,             NO₂, NR^(x)R^(y), (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,             (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,             (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, O—(C₁-C₄)alkyl, S—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, phenoxy,             (Het-1), and optionally R²⁰ and R²¹ together form a             (C₃-C₈)cycloalkyl,         -   wherein each alkyl, cycloalkyl, alkenyl, phenyl, and (Het-1)             substituent may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y),             (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl,             (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, O—(C₁-C₄)alkyl, S—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, phenoxy, and             (Het-1);

    -   (K) R¹⁶ and R¹⁷ along with C^(x)(Q²)(N^(x)), is (1g)

-   -   -   wherein, R¹⁸ and R¹⁹ are each independently selected from             the group consisting of H, F, Cl, Br, I, CN, NO₂, oxo,             thioxo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl,             (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and (Het-1);

    -   (L) R^(x) and R^(y) are each independently selected from the         group consisting of H, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl,         (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy,         (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,         S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,         OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)—(C₁-C₄)alkyl,         C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,         C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,         C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,         C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,         (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,         C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, and phenyl,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkoxy,             haloalkoxy, alkenyl, alkynyl, and phenyl may be optionally             substituted with one or more substituents independently             selected from the group consisting of H, F, Cl, Br, I, CN,             NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl,             (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and (Het-1);

    -   (M) (Het-1) is a 5- or 6-membered, saturated or unsaturated,         heterocyclic ring, containing one or more heteroatoms         independently selected from the group consisting of nitrogen,         sulfur, or oxygen,         -   wherein each heterocyclic ring may be optionally substituted             with one or more substituents independently selected from             the group consisting of H, F, Cl, Br, I, CN, NO₂, oxo,             (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl,             (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl,             (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl,             S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl,             OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy,         -   wherein each alkyl, haloalkyl, cycloalkyl, alkoxy,             haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy             substituent may be optionally substituted with one or more             substituents independently selected from the group             consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl,             (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy,             (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl,             S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl,             OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y),             (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl,             C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl,             C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl,             C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl,             C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl,             (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl,             C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy;             and

    -   (N) n are each independently 0, 1, or 2.

In another embodiment

-   -   (A) Ar¹ is (1a)

-   -   -   wherein, R¹, R², R³, R⁴, and R⁵ are each independently             selected from the group consisting of H, CH₃, CF₃, OCH₃,             OCF₃, OC₂H₅, and OC₂F₅;

    -   (B) Het is (1b)

-   -   -   wherein, R⁶ is H;

    -   (C) L¹ is

-   -   -   wherein R⁸ and R¹⁰ are each independently selected from the             group consisting of H, CH₃, CF₃, OCH₃, OCF₃, OC₂H₅, and             OC₂F₅;

    -   (D) Ar² is (1e)

-   -   -   wherein:         -   (1) X¹ is selected from the group consisting of N and CR¹³,         -   (2) X² is selected from the group consisting of N and CR¹⁴,             and         -   (3) R¹¹, R¹², R¹³, and R¹⁴ are each independently selected             from the group consisting of H, F, Cl, CH₃, CF₃, OCH₃, OCF₃,             OC₂H₅, and OC₂F₅;

    -   (E) R¹⁵ is H or CH₃;

    -   (F) Q¹ is O;

    -   (G) Q² is S;

    -   (H) R¹⁶ is (K);

    -   (I) R¹⁷ is (K);

    -   (J) L² is (1f)

-   -   -   wherein, R²⁰, R²¹, R²², R²³, and R²⁴ are each independently             selected from the group consisting of H, F, Cl, Br, CH₃,             OCH₃, CH₂CH₃, OCH₂CH₃, CH₂CH₂CH₃, OCH₂CH₂CH₃, CH₂CH₂CH₂CH₃,             CH(CH₃)₂, OCH(CH₃)₂, CH₂OCH₃, CH(CH₃)OCH₃, CH(CH₃)SCH₃, CF₃,             OCF₃, CH₂CF₃, OCH₂CF₃, CF₂CH₃, OCF₂CH₃, CF₂CF₃, OCF₂CF₃,             CH₂CH₂CF₃, OCH₂CH₂CF₃, CF₂CF₂CH₃, OCF₂CF₂CH₃, CF₂CF₂CF₃,             OCF₂CF₂CF₃, CF(CF₃)₂, OCF(CF₃)₂, CF₂OCF₃, CF(CF₃)OCF₃, and             optionally R²⁰ and R²¹ together form a (C₃-C₈)cycloalkyl;             and

    -   (K) R¹⁶ and R¹⁷ along with C^(x)(Q²)(N^(x)), is (1g)

-   -   -   wherein, R¹⁸ and R¹⁹ are each independently selected from             the group consisting of H, F, Cl, Br, CH₃, OCH₃, CF₃, OCF₃,             NH₂, and NO₂.

Preparation of Thiobiurets

Thiobiurets disclosed herein are prepared from the corresponding isocyanate, Ar¹-Het-Ar²-L¹-NCO (1-2). Usually, these isocyanates are not isolated, but are instead generated in situ from a suitable precursor and used directly in the preparation of a thiobiuret. One such suitable precursor is an amine (1-1) which can be converted into an isocyanate by using one of several common reagents such as phosgene, diphosgene, triphosgene, or carbonyldiimidazole (Scheme 1, step a), in a mixed solvent system such as dichloromethane and water or diethyl ether and water, in the presence of a base such as sodium bicarbonate or triethylamine, at temperatures from about −10° C. to about 50° C.

Alternatively, the isocyanates may be generated via a Curtius rearrangement of an acyl azide, Ar¹-Het-Ar²-L¹-C(O)N₃ (1-4), which is, in turn, prepared from the corresponding carboxylic acid precursor, Ar¹-Het-Ar²-L¹-CO₂H (1-3). Formation of an acyl azide (Scheme 1, step b) may be accomplished by one of several methods, including treatment of the acid with ethyl chloroformate and sodium azide in the presence of an amine base such as triethylamine, treatment of the acid with diphenylphosphoryl azide in the presence of an amine base such as triethylamine, or treatment of the acid with oxalyl chloride and a catalytic amount of dimethylformamide, followed by addition of the thus formed acid chloride to a solution of sodium azide. The acyl azide is then made to undergo a Curtius rearrangement (which may need to be thermally induced), leading to the corresponding isocyanate (1-2). Depending on the nature of the particular acyl azide, this rearrangement may occur spontaneously at ambient temperature, or it may require heating from about 40° C. to about 100° C. in a suitable solvent, such as toluene, or acetonitrile, or an ethereal solvent such as dioxane or tetrahydrofuran. The acyl azide intermediate is not always fully characterized, but may simply be heated directly without characterization, to generate the isocyanate.

An isocyanate, Ar¹-Het-Ar²-L¹-NCO (1-2), can be treated directly with an N-aryl thiourea (2-1) in the presence of about 0.1 to about 2 equivalents of an inorganic base such as cesium carbonate or sodium hydride, resulting in the formation of a thiobiuret (2-2, Scheme 2). The reaction can be performed at temperatures from about 0° C. to about 100° C., preferably from about 20° C. to about 80° C., in an aprotic solvent or solvent mixture chosen from acetonitrile, acetone, toluene, tetrahydrofuran, 1,2-dichloroethane, dichloromethane, or mixtures thereof, but use of acetonitrile is preferred.

Thiobiurets (2-2) generated in situ can be converted directly without purification into a variety of cyclized analogs (Scheme 3), or they can be isolated from the reaction medium prior to cyclization.

Cyclization can be achieved by treatment with an α-halo ester such as methyl bromoacetate to form 2-imino 1,3-thiazolin-4-ones (3-1, step a) unsubstituted or mono- or di-substituted; vicinal dihalides such as 1-bromo-2-chloroethane or 1,2-dichloroethane, to form 2-imino-1,3-thiazolines (3-2, step b) unsubstituted or mono-substituted; α-halo ketones such as chloroacetone to form 2-imino-1,3-thiazoles (3-3, step c) unsubstituted; or 1,3-dihalopropanes such as 1-bromo-3-chloro-propane to form 2-imino-1,3-thiazinanes (3-4, step d) unsubstituted or mono- or di-substituted. With step a, use of sodium acetate in a protic solvent such as ethanol or methanol, at temperatures ranging from about 20° C. to about 70° C. is preferred. With step b, use of an inorganic base such as potassium carbonate in a solvent such as acetonitrile or (preferably) 2-butanone, at a temperature between about 0° C. and about 80° C., is preferred.

An alternative method for preparing analogs having the general structure 3-1′ (Scheme 3) is described in Scheme 3a, Intermediate 2-iminothiazolidin-4-one (3-1a, step a) is reacted directly with an isocyanate (1-2), in the presence or absence of about 0.1 to about 2 equivalents of an inorganic base such as cesium carbonate or sodium hydride to form cyclized thiobiuret (3-1′). The reaction can be performed at temperatures from about 0° C. to about 100° C., preferably from about 20° C. to about 80° C., in an aprotic solvent or solvent mixture chosen from acetonitrile, acetone, toluene, tetrahydrofuran, 1,2-dichloroethane, dichloromethane, or mixtures thereof, but use of acetonitrile is preferred.

Alternatively, the 2-iminothiazolidin-2-one (3-1a) may be reacted with 4-nitrophenyl chloroformate (step b), forming a 4-nitrophenyl carbamate intermediate (3-2a). This reaction is conducted with equimolar quantities of the imine and the chloroformate, in a polar aprotic solvent such as tetrahydrofuran or dioxane, and in the presence of from about 0.1 to about 2 equivalents of an inorganic base such as cesium carbonate or potassium carbonate, preferably at room temperature. The intermediate (3-2a) may be isolated by filtration from inorganic salts and evaporation of solvent, or it can be used directly in step c. In step c, treatment of 3-2a with a primary alkyl amine Ar₁-Het-Ar₂-L-NHR¹, wherein R¹ is H or alkyl, may generate cyclized thiobiuret (3-1′). Step c may also be conducted in the presence of an inorganic base such as cesium carbonate or potassium carbonate, from about 0.1 to about 2 equivalents, preferably about 1 to about 1.2 equivalents; it is also most conveniently run at room temperature, although it may be run at temperatures from about 0° C. to about 100° C.

Thiobiurets (2-2) can also be converted into novel S-alkylated analogs as described in Scheme 3b. For example, reaction of a thiobiuret 2-2 with an alkyl iodide (step a), in a protic solvent such as ethanol, and in the presence of a base such as sodium acetate, at temperatures from about 0° C. to about 60° C., results in formation of an S—R² substituted product (3-1b). A variation of the reaction conditions described in Scheme 3, step c, employs careful control of reaction conditions to ensure that the temperature does not exceed 20° C. Under these conditions, 4-hydroxy-2-iminothiazolidines (3-2b, step b) may be isolated.

Analogs of Formula 1 wherein R² and R⁴ are cyclized to form a 2-(R⁵)-4-(R³)-5-imino-1,2,4-thiadiazolidin-3-one (3-4c) may be constructed as described in Scheme 3c. Following the work described by Kaugers, et al (J. Org. Chem 1992, 57, 1671), an N-arylamino 1,2,3,4-thiatriazole (3-1c), prepared in one step from the corresponding N³-aryl thiosemicarbazone by oxidation with sodium nitrite, is treated with an alkyl isocyanate to form 3-2c. Treatment of 3-2c with a base such as sodium methoxide in methanol at room temperature (step b) results in cleavage of the urea bond and formation of a 2-(R⁵)-4-(R³)-5-imino-1,2,4-thiadiazolidin-3-one (3-3c). This imine may then be treated with an isocyanate under conditions equivalent to those described in Scheme 3a, step a, to form 3-4c.

Preparation of Triaryl-Intermediates

Molecules of Formula One can be prepared by making a triaryl intermediate, Ar¹-Het-Ar², and then linking it to an appropriate intermediate to form a desired compound. A wide variety of triaryl intermediates can be used to prepare molecules of Formula One, provided that such triaryl intermediates contain a suitable functional group on Ar² to which the rest of the desired functional group can be attached. Suitable functional groups include an amino, isocyanate, carboxyl, or a halogen (preferably bromo or iodo). These triaryl intermediates can be prepared by methods previously described in the chemical literature, including Crouse, et al., WO2009102736 (the entire disclosure of which is hereby incorporated by reference).

The triaryl aldehydes used as precursors in preparation of the molecules of Formula One can be prepared according to procedures described in Crouse, et al., US 2012/0202688 A1. Some of the procedures described above require use of halo-aryl intermediates, Ar¹-Het-Ph-Br, which are novel intermediates. These may be prepared as described in Scheme 4. 3-(4-Bromophenyl)-1,2,4-triazole (4-2, step a) is prepared in two steps from 4-bromobenzamide (4-1) under conditions described previously (Crouse, et al., WO2009102736). This triazole can then be coupled to an aryl halide (R═C₁-C₆ haloalkoxy) such as 4-trifluoromethoxyphenyl bromobenzene, in the presence of cesium carbonate or potassium phosphate, in a polar aprotic solvent such as dimethylformamide. This reaction is catalyzed by a copper salt such as copper(I) iodide and a chelator such as 8-hydroxyquinoline, both present in about 0.05 to about 0.25 equivalents, at a temperature ranging between about 80° C. and about 140° C., to form the 1-aryl-3-(4-bromophenyl) triazole (4-4, step b).

Preparation of 2-Imino-1,3-Chalcogenazoheterocycles

Methods for preparation of the 2-imino-1,3-chalcogenazoheterocycles required for preparation of molecules of Formula One are described in Scheme 5. Anilines (5-1), wherein L² is as previously disclosed, may be treated with chloroacetyl chloride in the presence of a base, such as sodium bicarbonate, in a polar aprotic solvent, such as ethyl acetate, at temperatures from about −10° C. to about 30° C., to form amides (5-2), wherein L² is as previously disclosed (Scheme 10, step a). Treatment of amides (5-2) with potassium thiocyanate, in the presence of a base, such as cesium carbonate, in a polar solvent, such as acetone, at temperatures from about 50° C. to about 75° C., form 2-imino-1,3-chalcogenazoheterocycles (5-3), wherein L² is as previously disclosed (Scheme 10, step b).

Preparation of Compounds of Formula One

Accordingly, compounds of Formula One can be prepared, for example, as illustrated in Scheme 6, and exemplary compounds are shown in Table 1. Bromides (6-1), wherein Ar¹ and Het are as previously disclosed, may be treated with a hydroxy-substituted aryl boronate (6-2), wherein Ar² is as previously disclosed, under Suzuki coupling conditions with a catalyst such as tetrakis(triphenylphosphine)palladium(II), in a polar, protic solvent mixture such as dioxane-water, and in the presence of a base such as sodium bicarbonate at temperatures from about 50° C. to about 90° C. to provide triaryl alcohols (6-3), wherein Ar¹, Ar², and Het are as previously disclosed (step a, Scheme 6). The triaryl alcohols may be reacted with an alkylating agent such as ethyl 2-chloroacetate, in the presence of a base such as potassium carbonate, and in a polar, aprotic solvent such as N,N-dimethylformamide (DMF) at room temperature to provide the esters (6-4, step b). The esters, wherein Ar¹, Ar², and Het are as previously disclosed, may be saponified under basic conditions such as lithium hydroxide hydrate in the presence of a polar, protic solvent such as ethanol-water at room temperature to provide the terminal acids (6-5, step c). The acids may be converted to the acyl azides (6-6), wherein Ar¹, Ar², and Het are as previously disclosed, in two steps, first via reaction with a chlorinating reagent such as oxalyl chloride, with a catalytic amount of DMF, in a polar, aprotic solvent such as dichloromethane at room temperature to afford the acid chloride, which can be reacted with a source of azide such as sodium azide in a polar, aprotic solvent such as acetonitrile at room temperature (steps d and e). The acyl azides (6-6), wherein Ar¹, Ar², and Het are as previously disclosed, may be treated with 2-imino-1,3-chalcogenazoheterocycles (5-3), wherein L² is as previously disclosed, in a polar, aprotic solvent such as acetonitrile at temperatures from about 50° C. to about 90° C. to prepare compounds of Formula One, wherein Ar¹, Ar², Het, and L² are as previously disclosed.

TABLE 1 No. Structure  F1

 F2

 F3

 F4

 F5

 F6

 F7

 F8

 F9

F10

F11

F12

F13

F14

F15

F16

F17

F18

F19

F20

F21

F22

F23

F24

F25

F26

F27

F28

F29

F30

F31

F32

Compounds of the present invention may also be useful for increasing vigor of a crop plant. This method comprises contacting the crop plant (e.g., foliage flowers, fruit or roots) or the seed from which the crop plant is grown with a compound of Formula One in amount sufficient to achieve the desired plant vigor effect (i.e. biologically effective amount). Typically the compound of Formula One is applied in a formulated composition. Although the compound of Formula One is often applied directly to the crop plant or its seed, it can also be applied to the locus of the crop plant, i.e. the environment of the crop plant, particularly the portion of the environment in close enough proximity to allow the compound of Formula One to migrate to the crop plant. The locus relevant to this method most commonly comprises the growth medium (i.e. medium providing nutrients to the plant), typically soil in which the plant is grown. Treatment of a crop plant to increase vigor of the crop plant thus comprises contacting the crop plant, the seed from which the crop plant is grown or the locus of the crop plant with a biologically effective amount of a compound of Formula One.

Increased crop vigor can result in one or more of the following observed effects: (a) optimal crop establishment as demonstrated by excellent seed germination, crop emergence and crop stand; (b) enhanced crop growth as demonstrated by rapid and robust leaf growth (e.g., measured by leaf area index), plant height, number of tillers (e.g., for rice), root mass and overall dry weight of vegetative mass of the crop; (c) improved crop yields, as demonstrated by time to flowering, duration of flowering, number of flowers, total biomass accumulation (i.e. yield quantity) and/or fruit or grain grade marketability of produce (i.e. yield quality); (d) enhanced ability of the crop to withstand or prevent plant disease infections and arthropod, nematode or mollusk pest infestations; and (e) increased ability of the crop to withstand environmental stresses such as exposure to thermal extremes, suboptimal moisture or phytotoxic chemicals.

The compounds of the present invention can increase the vigor of treated plants compared to untreated plants by killing or otherwise preventing feeding of phytophagous invertebrate pests in the environment of the plants. In the absence of such control of phytophagous invertebrate pests, the pests reduce plant vigor by consuming plant tissues or sap, or transmitting plant pathogens such as viruses. Even in the absence of phytophagous invertebrate pests, the compounds of the invention may increase plant vigor by modifying metabolism of plants. Generally, the vigor of a crop plant will be most significantly increased by treating the plant with a compound of the invention if the plant is grown in a nonideal environment, i.e. an environment comprising one or more aspects adverse to the plant achieving the full genetic potential it would exhibit in an ideal environment.

Of note is the present method for increasing vigor of a crop plant wherein the crop plant is grown in an environment comprising phytophagous invertebrate pests. Also of note is the present method for increasing vigor of a crop plant wherein the crop plant is grown in an environment not comprising phytophagous invertebrate pests. Also of note is the present method for increasing vigor of a crop plant wherein the crop plant is grown in an environment comprising an amount of moisture less than ideal for supporting growth of the crop plant. Of note is the present method for increasing vigor of a crop plant wherein the crop is rice. Also of note is the present method for increasing vigor of a crop plant wherein the crop is maize (corn). Also of note is the present method for increasing vigor of a crop plant wherein the crop is soybean.

Compounds of this invention can also be mixed with one or more other biologically active compounds or agents including insecticides, fungicides, nematocides, bactericides, acaricides, herbicides, herbicide safeners, growth regulators such as insect molting inhibitors and rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stirulants, other biologically active compounds or entomopathogenic bacteria, virus or fungi to form a multi-component pesticide giving an even broader spectrum of agronomic and nonagronomic utility. Thus the present invention also pertains to a composition comprising a biologically effective amount of a compound of Formula One, at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, and at least one additional biologically active compound or agent. For mixtures of the present invention, the other biologically active compounds or agents can be Formulated together with the present compounds, including the compounds of Formula One, to form a premix, or the other biologically active compounds or agents can be Formulated separately from the present compounds, including the compounds of Formula One, and the two formulations combined together before application (e.g., in a spray tank) or, alternatively, applied in succession.

Examples of such biologically active compounds or agents with which compounds of this invention can be formulated are insecticides such as abamectin, acephate, acequinocyl, acetamiprid, acrinathrin, acynonapyr, afidopyropen ([(3S,4R,4aR,6S,6aS,12R,2aS,12b5)-3-[(cyclopropylcarbonyl)oxy]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-6,12-dihydroxy-4,6a,12b-trimethyl-1-oxo-9-(3-pyridinyl)-2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-4-yl]methyl cyclopropanecarboxylate), amidoflumnet, anmitraz, avermectin, azadirachtin, azinphos-methyl, benfuracarb, bensultap, benzpyrimoxan, bifenthrin, bifenazate, bistrifluron, borate, buprofezin, cadusafos, carbaryl, carbofuran, cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorpyrifos, chiorpyrifos-methyl, chromafenozide, clofentezin, clothianidin, cyantraniliprole (3-bromo-1--(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide), cyclaniliprole (3-bromo-N-[2-bromo-4-chloro-6-[[(1-cyclopropylethyl)amino]carbonyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide), cycloprothrin, cycloxaprid ((5S,8R)-1-[(6-chloro-3-pyridinyl)methyl]-2,3,5,6,7,8-hexa hydro-9-nitro-5,8-epoxy-1H-imidazo[1,2-a]azepine), cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, dimefluthrin, dimehypo, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenbutatin oxide, fenitrothion, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flometoquin (2-ethyl-3,7-dimethyl-6-[4-(trifluoromethoxy)phenoxy]-4-quinolinyl methyl carbonate), flonicamid, fluazaindolizine, flubendiamide, flucythrinate, flufenerim, flufenoxuron, flufenoxystrobin (methyl (αE)-2-[[2-chloro-4-(trifluoromethyl)phenoxy]methyl]-α-(methoxymnethyene) benzeneacetate), fluensulfone (5-chloro-2-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]thiazole), fluhexafon, fluopyram, flufiprole (1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[(2-methyl-2-propen-1-yl)amino]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile), flupyradifurone (4-[[(6-chloro-3-pyridinyl)methyl](2,2-difluoroethyl)amino]-2(5H)-furanone), flypyrimin, fluvalinate, tau-fluvalinate, fonophos, formetanate, fosthiazate, halofenozide, heptafluthrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl) phenyl]methyl 2,2-dimethyl-3-[(1Z)-3,3,3-trifluoro-1-propen-1-yl]cyclopropanecarboxylate), hexaflumuron, hexythiazox, hydramethylnon, imidacloprid, indoxacarb, insecticidal soaps, isofenphos, lufenuron, malathion, meperfluthrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl (1R,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate), metaflumizone, metaldehyde, methamidophos, methidathion, methiocarb, methomyl, methoprene, methoxychlor, methoxyfenozide, metofluthrin, monocrotophos, monofluorothrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 3-(2-cyano-1-propen-1-yl)-2,2-dimethylcyclopropanecarboxylate), nicotine, nitenpyram, nithiazine, novaluron, noviflumuron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, propargite, protrifenbute, pyflubumide (1,3,5-trimethyl-N-(2-methy-1-oxopropyl)-N-[3-(2-methylpropyl)-4-[2,2,2-trifluoro-1-methoxy-1-(trifluoromethyl)ethyl]phenyl]-1H-pyrazole-4-carboxamide), pymetrozine, pyrafluprole, pyrethrin, pyridaben, pyridalyl, pyrifluquinazon, pyriminostrobin (methyl (αE)-2-[[[2-[(2,4-dichlorophenyl)amino]-6-(trifluoromethyl)-4-pyrimidinyl]oxy]methyl]-α-(methoxymethylene) benzeneacetate), pyriprole, pyriproxyfen, rotenone, ryanodine, silafluofen, spinetoram, spinosad, spirodiclofen, spirodion, spiromesifen, spirotetramat, sulprofos, sulfoxaflor (N-[methyloxido[1-[6-(trifluoromethyl)-3-pyridinyl]ethyl]-λ^(∝)-sulfanylidene]cyanamide), tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, tetramethrin, tetramethylfluthrin ([2,3,5,6-tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2,3,3-tetramethylcyclopropanecarboxylate), tetraniliprole, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tioxazafen (3-phenyl-5-(2-thienyl)-1,2,4-oxadiazole), tolfenpyrad, tralomethrin, triazamate, trichlorfon, triflumezopyrim (2,4-dioxo-1-(5-pyrimidinylmethyl)-3-[3-(trifluoromethyl)phenyl]-2H-pyrido[1,2-a]pyrimidinium inner salt), triflumuron, tyclopyrazoflor, Bacillus thuringiensis delta-endotoxins, entomopathogenic bacteria, entomopathogenic viruses and entomopathogenic fungi.

Of note are insecticides such as abamectin, acetamiprid, acrinathrin, afidopyropen, amitraz, avermectin, azadirachtin, benfuracarb, bensultap, bifenthrin, buprofezin, cadusafos, carbaryl, cartap, chlorantraniliprole, chlorfenapyr, chlorpyrifos, clothianidin, cyantraniliprole, cyclaniliprole, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gammacyhalothrin, lamba-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, dieldrin, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenitrothion, fenothiocarb, fenoxycarb, fenvalerate, Fipronil, flometoquin, flonicamid, flubendiamide, flufenoxuron, flufenoxystrobin, flufensulfone, flupiprole, flupyradifurone, fluvalinate, formetanate, fosthiazate, heptafluthrin, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, lufenuron, meperfluthrin, metaflumizone, methiocarb, methomyl, methoprene, methoxyfenozide, metofluthrin, monofluorothrin, nitenpyram, nithiazine, novaluron, oxamyl, pyflubumide, pymetrozine, pyrethrin, pyridaben, pyridalyl, pyririnostrobin, pyriproxyfen, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetra mat, sulfoxaflor, tebufenozide, tetramethrin, tetramethylfluthrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, triflumezopyrim, triflumuron, Bacillus thuringiensis delta-endotoxins, all strains of Bacillus thuringiensis and all strains of nucleo polyhedrosis viruses.

One embodiment of biological agents for mixing with compounds of this invention include entomopathogenic bacteria such as Bacillus thuringiensis, and the encapsulated delta-endotoxins of Bacillus thuringiensis such as MVP® and MVPII® bioinsecticides prepared by the CellCap® process (CellCap®, MVP; and MVPII® are trademarks of Mycogen Corporation, Indianapolis, Ind., USA); entomopathogenic fungi such as green muscardine fungus; and entomopathogenic (both naturally occurring and genetically modified) viruses including baculovirus, nucleopolyhedrovirus (NPV) such as Helicoverpa zea nucleopolyhedrovirus (HzNPV), Anagrapha falcifera nucleopolyhedrovirus (AfNPV); and granulosis virus (GV) such as Cydia pomonella granulosis virus (CpGV).

Of particular note is such a combination where the other invertebrate pest control active ingredient belongs to a different chemical class or has a different site of action than the compound of Formula One. In certain instances, a combination with at least one other invertebrate pest control active ingredient having a similar spectrum of control but a different site of action will be particularly advantageous for resistance management. Thus, a composition of the present invention can further comprise a biologically effective amount of at least one additional invertebrate pest control active ingredient having a similar spectrum of control but belonging to a different chemical class or having a different site of action. These additional biologically active compounds or agents include, but are not limited to, acetylcholinesterase (AChE) inhibitors such as the carbamates methomyl, oxamyl, thiodicarb, triazamate, and the organophosphates chlorpyrifos; GABA-gated chloride channel antagonists such as the cyclodienes dieldrin and endosulfan, and the phenylpyrazoles ethiprole and fipronil; sodium channel modulators such as the pyrethroids bifenthrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, deltamethrin, dimefluthrin, esfenvalerate, metofluthrin and profluthrin; nicotinic acetylcholinereceptor (nAChR) agonists such as the neonicotinoids acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid, and thiamethoxam, and sulfoxaflor; nicotinic acetylcholine receptor (nAChR) allosteric activators such as the spinosyns spinetoram and spinosad; chloride channel activators such as the avermectins abamectin and emamectin; juvenile hormone mimics such as diofenolan, methoprene, fenoxycarb and pyriproxyfen; selective homopteran feeding blockers such as pymetrozine and flonicamid; mite growth inhibitors such as etoxazole; inhibitors of mitochondrial ATP synthase such as propargite; ucouplers of oxidative phosphorylation via disruption of the proton gradient such as chlorfenapyr; nicotinic acetylcholine receptor (nAChR) channel blockers such as the nereistoxin analogs cartap; inhibitors of chitin biosynthesis such as the benzoylureas flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron and triflumuron, and buprofezin; dipteran moulting disrupters such as cyromazine; ecdysone receptor agonists such as the diacylhydrazines methoxyfenozide and tebufenozide; octopamine receptor agonists such as amitraz; mitochondrial complex III electron transport inhibitors such as hydramethylnon; mitochondrial complex I electron transport inhibitors such as pyridaben; voltage-dependent sodium channel blockers such as indoxacarb; inhibitors of acetyl CoA carboxyiase such as the tetronic and tetramic acids spirodiciofen, spiromesifen and spirotetramat; mitochondrial complex II electron transport inhibitors such as the ß-ketonitriles cyenopyrafen and cyflumetofen; ryanidine receptor modulators such as the anthranilic diamides chlorantraniliprole, cyantraniliprole and cyantraniliprole, diamides such as flubendiamide, and ryanodine receptor ligands such as ryanodine; compounds wherein the target site responsible for biological activity is unknown or uncharacterized such as azadirachtin, bifenazate, pyridalyl, pyrifluquinazon and triflumezopyrim; microbial disrupters of insect midgut membranes such as Bacillus thuringensis and the delta-endotoxins they produce and Bacillius sphaericus; and biological agents including nucleo polyhedro viruses (NPV) and other naturally occurring or genetically modified insecticidal viruses.

Further examples of biologically active compounds or agents with which compounds of this invention can be formulated are: fungicides such as acibenzolar-S-methyl, aldimorph, ametoctradin, amisulbrom, anilazine, azaconazole, azoxystrobin, benalaxyl (including benalaxyl-M), benodanil, benomyl, benthiavalicarb (including benthiavalicarb-isopropyl), benzovindiflupyr, bethoxazin, binapacryl, biphenyl, bitertanol, bixafen, blasticidin-S, boscalid, bromuconazole, bupirimate, buthiobate, carboxin, carpropamid, captafol, captan, carbendazim, chloroneb, chlorothalonil, chlozolinate, copper hydroxide, copper oxychloride, copper sulfate, coumoxystrobin, cyazofamid, cyflufenamnid, cymoxanil, cyproconazole, cyprodinil, dichlofluanid, diclocymet, diclomezine, dicloran, diethofencarb, difenoconazole, diflumetorim, dimethirimol, dimethomorph, dimoxystrobin, diniconazole (including diniconazole-M), dinocap, dithianon, dithiolanes, dodemorph, dodine, econazole, etaconazole, edifenphos, enoxastrobin (also known as enestroburin), epoxiconazole, ethaboxam, ethirimol, etridiazole, famoxadone, fenamidone, fenaminstrobin, fenarimol, fenbuconazole, fenfuram, fenhexamide, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, fenpyrazamine, fentin acetate, fentin hydroxide, ferbam, ferimzone, flometoquin, fluazinam, fludioxonil, flufenoxystrobin, flumorph, fluopicolide, fluopyram, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutianil, flutolanil, flutriafol, fluxapyroxad, folpet, fthalide (also known as phthalide), fuberidazole, furalaxyl, furametpyr, hexaconazole, hymexazoie, guazatine, imazalil, imibenconazole, iminoctadine albesiiate, iminoctadine triacetate, iodicarb, ipconazole, isofetamid, iprobenfos, iprodione, iprovalicarb, isoprothiolane, isopyrazam, isotianil, kasugamycin, kresoxim-methyl, mancozeb, mandipropamid, mandestrobin, maneb, mapanipyrin, mepronil, meptyldinocap, metalaxyl (including metalaxyl-M/mefenoxam), metconazole, methasulfocarb, metiram, metominostrobin, metrafenone, myclobutanil, naftitine, neo-asozin (ferric methanearsonate), nuarimol, octhilinone, ofurace, orysastrobin, oxadixyl, oxathiapiprolin, oxolinic acid, oxpoconazole, oxycarboxin, oxytetracycline, penconazole, pencycuron, penflufen, penthiopyrad, perfurazoate, phosphorous acid (including salts thereof, e.g., fosetyl-alumninm), picarbutratox, picoxystrobin, piperalin, polyoxin, probenazole, prochloraz, procymidone, propamocarb, propiconazole, propineb, proquinazid, prothiocarb, prothioconazole, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyrazophos, pyribencarb, pyributacarb, pyrifenox, pyriofenone, perisoxazole, pyrimethanil, pyrifenox, pyrrolnitrin, pyroquilon, quinconazole, quinmethionate, quinoxyfen, quintozene, silthiofam, sedaxane, simeconazole, spiroxamine, streptomycin, suifur, tebuconazole, tebufloquin, teclofthalam, tecloftalam, tecnazene, terbinafine, tetraconazole, thiabendazole, thifluzamide, thiophanate, thiophanate-methyi, thiram, tiadinil, tolclofos-methyl, tolprocarb, tolyfluanid, triadimefon, triadimenol, triarimoi, triazoxide, tribasic copper sulfate, triclopyricarb, tridemorph, trifloxystrobin, triflumizole, trimoprhamide tricyclazole, triforine, triticonazole, uniconazole, validamycin, valifenalate (also known as valifenal), vinclozolin, zineb, ziram and zoxamide; nematocides such as fluopyram, spirotetramat, thiodicarb, fosthiazate, abamectin, iprodione, fluensulfone, dimethyl disulfide, tioxazafen, 1,3-dichloropropene (1,3-D), metam (sodium and potassium), dazomet, chloropicrin, fenamiphos, ethoprophos, cadusaphos, terbufos, imicyafos, oxamyl, carbofuran, tioxazafen, Bacillus firmus and Pasteuria nishizawae; bactericides such as streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad.

In certain instances, combinations of a compound of this invention with other biologically active (particularly invertebrate pest control) compounds or agents (i.e. active ingredients) can result in a greater-than-additive (i.e. synergistic) effect. Reducing the quantity of active ingredients released in the environment while ensuring effective pest control is always desirable. When synergism of invertebrate pest control active ingredients occurs at application rates giving agronomically satisfactory levels of invertebrate pest control, such combinations can be advantageous for reducing crop production cost and decreasing environmental load.

Compounds of this invention and compositions thereof can be applied to plants genetically transformed to express proteins toxic to invertebrate pests (such as Bacillus thuringiensis delta-endotoxins). Such an application may provide a broader spectrum of plant protection and be advantageous for resistance management. The effect of the exogenously applied invertebrate pest control compounds of this invention may be synergistic with the expressed toxin proteins.

General references for these agricultural protectants (i.e. insecticides, fungicides, nematocides, acaricides, herbicides and biological agents) include The Pesticide Manual, 13th Edition, C. D. S. Tomlin, Ed., British Crop Protection Council, Farnham, Surrey, U. K., 2003 and The BioPesticide Manual, 2^(nd) Edition, L. G. Copping, Ed., British Crop Protection Council, Farnham, Surrey, U. K., 2001.

Compounds of this invention can be combined or formulated with polynucleotides including, but not limited to, DNA, RNA, and/or chemically modified nucleotides influencing the amount of a particular target through down regulation, interference, suppression or silencing of the genetically derived transcript that render an insecticidal effect.

For embodiments where one or more of these various mixing partners are used, the weight ratio of these various mixing partners (in total) to the compound of Formula One is typically between about 1:3000 and about 3000:1. Of note are weight ratios between about 1:300 and about 300:1 (for example ratios between about 1:30 and about 30:1). One skilled in the art can easily determine through simple experimentation the biologically effective amounts of active ingredients necessary for the desired spectrum of biological activity. It will be evident that including these additional components can expand the spectrum of invertebrate pests controlled beyond the spectrum controlled by the compound of Formula One alone.

Table A lists specific combinations of a compound of Formula One with other invertebrate pest control agents illustrative of the mixtures, compositions and methods of the present invention. The first column of Table A lists the specific invertebrate pest control agents (e.g., “Abamectin” in the first line). The second column of Table A lists the mode of action (if known) or chemical class of the invertebrate pest control agents. The third column of Table A lists embodiment(s) of ranges of weight ratios for rates at which the invertebrate pest control agent can be applied relative to a compound of Formula One (e.g., “50:1 to 1:50” of abamectin relative to a compound of Formula One by weight). Thus, for example, the first line of Table A specifically discloses the combination of a compound of Formula One with abamectin can be applied in a weight ratio between 50:1 to 1:50. The remaining lines of Table A are to be construed similarly. Of further note Table A lists specific combinations of a compound of Formula One with other invertebrate pest control agents illustrative of the mixtures, compositions and methods of the present invention and includes additional embodiments of weight ratio ranges for application rates.

TABLE A Invertebrate Pest Mode of Action or Typical Control Agent Chemical Class Weight Ratio Abamectin Chloride channel activator 50:1 to 1:50 Acetamiprid Nicotinic acetylcholine 150:1 to 1:200 receptor (nAChR) agonist Amitraz Octopamine receptor 200:1 to 1:100 agonist Avermectin Macrocyclic lactones 50:1 to 1:50 Azadirachtin Unknown site of action 100:1 to 1:120 Beta-cyfluthrin Sodium channel 150:1 to 1:200 modulators Bifenthrin Sodium channel 100:1 to 1:10  modulators Buprofezin Chitin biosynthesis 500:1 to 1:50  inhibitors Cartap Nicotinic acetylcholine 100:1 to 1:200 receptor (nAChR) channel biocker Chlorantraniliprole Ryanodine receptor 100:1 to 1:120 modulator Chlorfenapyr Uncouplers of oxidative 300:1 to 1:200 phosphorylation Chlorpyrifos Acetylcholine esterase 500:1 to 1:200 inhibitor Clothianidin Nicotinic acetylcholine 100:1 to 1:400 receptor (nAChR) agonist Cyantraniliprole Ryanodine receptor 100:1 to 1:120 modulator Cyfluthrin Sodium channel modulator 150:1 to 1:200 Cyhalothrin Sodium channel modulator 150:1 to 1:200 Cypermethrin Sodium channel modulator 150:1 to 1:200 Cyromazine Dipteran moulting disrupter 400:1 to 1:50  Deltamethrin Sodium channel  50:1 to 1:400 modulators Dieldrin GABA-gated chloride 200:1 to 1:100 channel antagonist Dinotefuran Nicotinic acetylcholine 150:1 to 1:200 receptor (nAChR) agonist Diofenolan Juvenile hormone mimic 150:1 to 1:200 Emamectin Chloride channel activator 50:1 to 1:10 Endosulfan GABA-gated chloride 200:1 to 1:100 channel antagonist Esfenvalerate Sodium channel modulator 100:1 to 1:400 Ethiprole GABA-regulated chloride 200:1 to 1:100 channel antagonist Fenothiocarb 150:1 to 1:200 Fenoxycarb Juvenile hormone mimic 500:1 to 1:100 Fenvalerate Sodium channel modulator 150:1 to 1:200 Fipronil GABA-regulated chloride 150:1 to 1:100 channel antagonist Flonicamid Selective homopteran 200:1 to 1:100 feeding blocker Flubendiamide Ryanodine receptor 100:1 to 1:120 modulator Flufenoxuron Chitin biosynthesis inhibitor 200:1 to 1:100 Hexaflumuron Chitin biosynthesis inhibitor 300:1 to 1:50  Hydramethylnon Mitochondrial complex III 150:1 to 1:250 electron transport inhibitor Imidacloprid Nicotinic acetylcholone 1000:1 to 1:1000 receptor (nAChR) agonist Indoxacarb Voltage-dependent sodium 200:1 to 1:50  channel blocker Lambda-cyhalothrin Sodium channel modulator  50:1 to 1:250 Lufenuron Chitin biosynthesis inhibitor 500:1 to 1:250 Metaflumizone Voltage-depedent sodium 200:1 to 1:200 channel blocker Methomyl Acetylcholine esterase 500:1 to 1:100 inhibitor Methoprene Juvenile hormone mimic 500:1 to 1:100 Methoxyfenozide Ecdysone receptor agonist 50:1 to 1:50 Nitenpyram Nicotinic acetylcholine 150:1 to 1:200 receptor (nAChR) agonist Nithiazine Nicotinic acetylcholine 150:1 to 1:200 receptor (nAChR) agonist Novaluron Chitin biosynthesis inhibitor 500:1 to 1:150 Oxamyl Acetylcholine esterase 200:1 to 1:200 inhibitor Pymetrozine Selective homopteran 200:1 to 1:100 feeding blocker Pyrethrin Sodium channel modulator 100:1 to 1:10  Pyridaben Mitochondrial complex I 200:1 to 1:100 electron transport inhibitor Pyridalyl Unknown site of action 200:1 to 1:100 Pyriproxyfen Juventile hormone mimic 500:1 to 1:100 Ryanodine Ryanodine receptor ligand 100:1 to 1:120 Spinetoram Nicotinic acetylcholine 150:1 to 1:100 receptor (nAChR) allosteric activator Spinosad Nicotinic acetylcholine 500:1 to 1:10  receptor (nAChR) allosteric activator Spirodiclofen Acetyl CoA carboxylase 200:1 to 1:200 inhibitor Spiromesifen Acetyl CoA carboxylase 200:1 to 1:200 inhibitor Tebufenozide Ecdsone receptor agonist 500:1 to 1:250 Thiacloprid Nicotinic acetylcholine 100:1 to 1:200 receptor (nAChR) agonist Thiamethoxam Nicotinic acetylcholine 1250:1 to 1:1000 receptor (nAChR) agonist Thiodicarb Acetylcholine esterase 500:1 to 1:400 inhibitor Thiosultap-sodium Nicotinic acetylcholine 150:1 to 1:100 receptor (nAChR) channel blocker Tralomethrin Sodium channel modulator 150:1 to 1:200 Triazamate Acetylcholine esterase 250:1 to 1:100 inhibitor Triflumezopyrim 100:1 to 1:100 Triflumuron Chitin synthesis inhibitor 200:1 to 1:100 Bacillus thuringiensis Biological agents 50:1 to 1:10 Bacillus thuringiensis Biological agents 50:1 to 1:10 Delta-endotoxin NPV (e.g., Gemstar) Biological agents 50:1 to 1:10

EXAMPLES Example 1: Preparation of 4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenol (C1)

3-Bromo-1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazole (1 grams (g), 3.25 millimoles (mmol)), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (0.714 g, 3.25 mmol), and sodium bicarbonate (0.818 g, 9.74 mmol) were stirred together in dioxane (50 milliliters (mL)) and water (15 mL) at room temperature (rt). Tetrakis(triphenylphosphine)palladium(0) (0.375 g, 0.325 mmol) was added, and the mixture was warmed to 75° C. for 3 hours (h) then a left at rt for 16 h. The mixture was evaporated to ˜½ volume and partitioned between ethyl acetate (EtOAc) and water. The combined organic extracts were dried over magnesium sulfate (MgSO₄). Purification by silica gel chromatography eluting with 0-30% EtOAc in hexanes yielded a white solid (0.51 g, 47%): mp 182-184° C.; ¹H NMR (500 MHz, CDCl₃) δ 8.55 (s, 1H), 8.10-8.05 (m, 2H), 7.82-7.76 (m, 2H), 7.41-7.35 (m, 2H), 6.95-6.90 (m, 2H), 5.85 (s, 1H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03; ¹³C NMR (126 MHz, CDCl₃) δ 163.29, 157.29, 148.34, 141.36, 135.57, 128.33, 123.38, 122.94, 122.40, 121.42, 121.16, 119.36, 117.37, 115.67; ESIMS m/z 322 ([M+H]⁺).

Example 2: Preparation of ethyl 2-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)acetate (C2)

4-(1-(4-(Trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenol (C1; 500 milligrams (mg), 1.556 mmol) and potassium carbonate (473 mg, 3.42 mmol) were stirred in N,N-dimethylformamide (DMF; 10 mL) for 30 minutes (min) at rt. A solution of ethyl 2-chloroacetate (210 mg, 1.71 mmol) in DMF (5 mL) was added dropwise, and the mixture was stirred for an additional 4 h. Ice was added to the reaction mixture, and it was further diluted with water. The solid product was filtered from the aqueous mixture. The title compound was isolated as a pale tan solid (590 mg, 93%): mp 112-113° C.; ¹H NMR (500 MHz, CDCl₃) δ 8.54 (s, 1H), 8.16-8.10 (m, 2H), 7.82-7.76 (m, 2H), 7.42-7.35 (m, 2H), 7.04-6.98 (m, 2H), 4.69 (s, 2H), 4.29 (q, J=7.1 Hz, 2H), 1.31 (t, J=7.1 Hz, 3H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03; ESIMS m/z 408 ([M+H]⁺).

Example 3: Preparation of 2-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)acetic acid (C3)

Ethyl 2-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)acetate (C2; 0.52 g, 1.277 mmol) was stirred in ethanol (EtOH; 20 mL) and water (10 mL). Lithium hydroxide hydrate (67 mg, 1.60 mmol) was added, and the reaction mixture was stirred at room temperature for 16 h. The mixture was diluted with water, acidified with 1N HCl, and filtered. The wet solid was dried in a vacuum oven at 50° C. for 3 h. The title compound was isolated as an off-white solid (0.49 g, 100%): mp 190-191° C.; ¹H NMR (500 MHz, methanol-d₄) δ 9.10 (s, 1H), 8.11-8.03 (m, 2H), 8.03-7.97 (m, 2H), 7.52-7.44 (m, 2H), 7.09-7.01 (m, 2H), 4.72 (s, 2H); ¹⁹F NMR (471 MHz, methanol-d₄) δ −59.68; ESIMS m/z 380 ([M+H]⁺).

Example 4: Preparation of 2-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)acetyl azide (C4)

2-(4-(1-(4-(Trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)acetic acid (C3; 230 mg, 0.606 mmol) was taken up as a slurry and stirred in dichloromethane (25 mL). Oxalyl chloride (231 micoliters (μL), 2.64 mmol) and DMF (2 drops) were added sequentially. The reaction mixture was stirred at rt for 2 h and evaporated to a white solid. The crude intermediate acid chloride thus prepared was slurried in acetonitrile (10 mL), added to a solution of sodium azide (197 mg, 3.03 mmol) in water (4 mL), and stirred for 30 min. The mixture was diluted with water, cooled to 0° C., and filtered. The title compound was isolated as an off-white solid (220 mg, 90%): ¹H NMR (500 MHz, CDCl₃) δ 8.54 (s, 1H), 8.16-8.13 (m, 2H), 7.81-7.76 (m, 2H), 7.41-7.36 (m, 2H), 7.02-6.98 (m, 2H), 4.72 (s, 2H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03; ESIMS m/z 405 ([M+H]⁺).

Example 5: Preparation of (Z)-1-(3-(2-isopropyl-5-methylphenyl)-4-oxothiazolidin-2-ylidene)-3-((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)urea (F1)

2-(4-(1-(4-(Trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)acetyl azide (C4; 38 mg, 0.094 mmol) and 2-imino-3-(2-isopropyl-5-methylphenyl)thiazolidin-4-one (28.0 mg, 0.113 mmol) were stirred together in acetonitrile (3 mL) and immediately heated to 70° C. for 10 min. The crude reaction mixture was cooled to room temperature and adsorbed onto silica gel. Purification by silica gel chromatography eluting with 0-70% EtOAc in hexanes afforded the title compound as a yellow solid foam (35 mg, 57%): ¹H NMR (500 MHz, CDCl₃) δ 8.52 (s, 1H), 8.12-8.07 (m, 2H), 7.80-7.76 (m, 2H), 7.40-7.35 (m, 2H), 7.32 (d, J=8.0 Hz, 1H), 7.27-7.24 (m, 1H), 7.05-7.00 (m, 2H), 6.86-6.83 (m, 1H), 6.28 (t, J=7.2 Hz, 1H), 5.32 (ddd, J=43.2, 10.3, 7.3 Hz, 2H), 3.99-3.88 (m, 2H), 2.61 (hept, J=6.8 Hz, 1H), 2.33 (s, 3H), 1.17-1.11 (m, 6H); ¹⁹F NMR (471 MHz, CDCl₃) 5-58.03; ¹³C NMR (126 MHz, CDCl₃) δ 172.55, 163.23, 161.81, 157.86, 148.30, 143.14, 141.40, 136.83, 135.61, 132.28, 131.19, 128.49, 128.10, 126.67, 123.98, 122.39, 121.12, 115.72, 69.39, 33.03, 28.34, 23.84, 20.78; ESIMS m/z 626 ([M+H]⁺).

The following compounds were prepared according to the procedures disclosed in Example 5:

(Z)-1-(3-(5-Methoxy-2-(2,2,2-trifluoroethyl)phenyl)-4-oxothiazolidin-2-ylidene)-3-((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)urea (F2)

The title compound was isolated as an off-white solid (26 mg, 51%): mp 181-184° C.; ¹H NMR (500 MHz, CDCl₃) δ 8.53 (s, 1H), 8.12-8.08 (m, 2H), 7.80-7.76 (m, 2H), 7.40-7.35 (m, 3H), 7.05-6.98 (m, 3H), 6.68 (d, J=2.7 Hz, 1H), 6.26 (t, J=7.3 Hz, 1H), 5.33 (ddd, J=49.7, 10.2, 7.2 Hz, 2H), 4.00-3.89 (m, 2H), 3.80 (s, 3H), 3.23-3.09 (m, 2H); ¹³C NMR (126 MHz, CDCl₃) δ 171.76, 170.18, 163.20, 161.54, 160.26, 157.81, 148.30, 141.40, 135.60, 135.41, 132.87, 128.14, 124.04, 122.39, 121.12, 115.98, 115.66, 114.52, 69.35, 55.57, 35.39, 33.00; ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03, −64.76 (t, J=10.7 Hz); ESIMS m/z 681 ([M+H]⁺).

(Z)-1-(3-(5-Methyl-2-(2,2,2-trifluoroethoxy)phenyl)-4-oxothiazolidin-2-ylidene)-3-((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)urea (F23)

The title compound was isolated as a white solid (30 mg, 55%): mp 153-155° C.; ¹H NMR (500 MHz, CDCl₃) δ 8.52 (s, 1H), 8.12-8.07 (m, 2H), 7.80-7.75 (m, 2H), 7.39-7.35 (m, 2H), 7.23 (dd, J=8.4, 2.1 Hz, 2H), 7.05-7.01 (m, 2H), 7.01 (d, J=2.1 Hz, 1H), 6.92 (d, J=8.4 Hz, 1H), 6.24 (t, J=7.3 Hz, 1H), 5.33 (ddd, J=58.5, 10.3, 7.3 Hz, 2H), 4.37-4.24 (m, 2H), 3.97-3.85 (m, 2H), 2.34 (s, 3H); ¹³C NMR (126 MHz, CDCl₃) δ 171.99, 170.61, 163.22, 161.69, 157.86, 150.37, 148.27, 141.39, 135.61, 133.21, 131.55, 130.38, 128.12, 124.28, 123.94, 122.38, 121.81, 121.11, 115.62, 114.26, 69.32, 67.26, 66.97, 66.69, 66.40, 32.88, 20.55; ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03, −74.14 (t, J=7.8 Hz); ESIMS m/z 681 ([M+H]⁺).

(Z)-1-(3-(2-Isopropyl-5-methyl phenyl)-4-oxothiazolidin-2-ylidene)-3-(1-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)ethyl)urea (F24)

The title compound was isolated as a pale tan foam (39 mg, 20%): ¹H NMR (500 MHz, CDCl₃) δ 8.53 (s, 1H), 8.11-8.07 (m, 2H), 7.81-7.76 (m, 2H), 7.41-7.35 (m, 2H), 7.33-7.24 (m, 2H), 7.12-7.06 (m, 2H), 6.86-6.82 (m, 1H), 6.12-6.03 (m, 1H), 5.91-5.86 (m, 1H), 3.96-3.88 (m, 2H), 2.66-2.48 (m, 1H), 2.38-2.28 (m, 3H), 1.55-1.51 (m, 2H), 1.20-0.99 (m, 6H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03; ESIMS m/z 637 ([M+H]⁺).

(Z)-1-(3-(2-Ethoxyphenyl)-4-oxothiazolidin-2-ylidene)-3-((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)urea (F25)

The title compound was isolated as a pale tan solid (20 mg, 42%): ¹H NMR (500 MHz, CDCl₃) δ 8.54 (s, 1H), 8.14-8.09 (m, 2H), 7.81-7.76 (m, 2H), 7.47 (ddd, J=8.3, 7.5, 1.7 Hz, 1H), 7.40-7.35 (m, 2H), 7.26 (dd, J=7.8, 1.7 Hz, 1H), 7.11-7.07 (m, 2H), 7.06-7.01 (m, 2H), 5.47 (qd, J=9.9, 6.7 Hz, 2H), 4.07 (q, J=7.0 Hz, 2H), 3.82 (s, 2H), 1.29 (t, J=7.0 Hz, 3H); ¹³C NMR (126 MHz, CDCl₃) δ 186.65, 186.50, 163.27, 157.92, 155.15, 151.90, 148.24, 141.37, 135.63, 132.18, 130.63, 128.13, 125.77, 124.02, 123.47, 122.38, 121.42, 121.09, 120.84, 119.37, 117.31, 115.79, 113.37, 69.68, 64.52, 39.55, 14.59; ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03; ESIMS m/z 613 ([M+H]⁺).

Methyl (Z)-3-methyl-4-(4-oxo-2-((((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)carbamoyl)imino)thiazolidin-3-yl)benzoate (F26)

The title compound was isolated as a pale yellow oil (37 mg, 62%): ¹H NMR (500 MHz, CDCl₃) δ 8.52 (s, 1H), 8.11-8.07 (m, 2H), 8.01 (d, J=1.9 Hz, 1H), 7.95 (dd, J=8.1, 1.9 Hz, 1H), 7.80-7.75 (m, 2H), 7.39-7.35 (m, 2H), 7.16 (d, J=8.2 Hz, 1H), 7.04-6.99 (m, 2H), 6.27 (t, J=7.2 Hz, 1H), 5.36-5.26 (m, 2H), 3.98-3.94 (m, 2H), 3.92 (s, 3H), 2.18 (s, 3H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03; ESIMS m/z 641 ([M+H]⁺).

(Z)-1-(4-Oxo-3-(5,6,7,8-tetrahydronaphthalen-1-yl)thiazolidin-2-ylidene)-3-((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)urea (F27)

The title compound was isolated as a pale yellow solid (20 mg, 34%): ¹H NMR (500 MHz, CDCl₃) δ 8.52 (s, 1H), 8.12-8.07 (m, 2H), 7.80-7.76 (m, 2H), 7.39-7.35 (m, 2H), 7.23-7.16 (m, 2H), 7.05-7.01 (m, 2H), 6.90 (dd, J=7.0, 2.1 Hz, 1H), 6.30 (t, J=7.2 Hz, 1H), 5.36-5.28 (m, 2H), 3.96-3.90 (m, 2H), 2.84-2.79 (m, 2H), 2.46-2.41 (m, 2H), 1.80-1.72 (m, 4H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03; ESIMS m/z 623 ([M+H]⁺).

(Z)-1-(3-(2-Butylphenyl)-4-oxothiazolidin-2-ylidene)-3-((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)urea (F28)

The title compound was isolated as a pale yellow oil (16 mg, 27%): ¹H NMR (500 MHz, CDCl₃) δ 8.54 (s, 1H), 8.13-8.10 (m, 2H), 7.81-7.77 (m, 2H), 7.47 (td, J=7.5, 1.4 Hz, 1H), 7.40-7.36 (m, 3H), 7.33 (td, J=7.7, 1.6 Hz, 1H), 7.22 (dd, J=7.9, 1.3 Hz, 1H), 7.11-7.07 (m, 2H), 5.51-5.44 (m, 2H), 3.82 (s, 2H), 2.46-2.41 (m, 2H), 1.58-1.50 (m, 2H), 1.34-1.28 (m, 2H), 0.86 (t, J=7.3 Hz, 3H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03; ESIMS m/z 625 ([M+H]⁺).

(Z)-1-(3-(2-Fluoro-5-methylphenyl)-4-oxothiazolidin-2-ylidene)-3-((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)urea (F29)

The title compound was isolated as a pale yellow oil (60 mg, 81%): ¹H NMR (500 MHz, CDCl₃) δ 8.52 (s, 1H), 8.13-8.06 (m, 2H), 7.80-7.76 (m, 2H), 7.39-7.35 (m, 2H), 7.25-7.20 (m, 1H), 7.12-7.07 (m, 1H), 7.05-6.99 (m, 3H), 6.30 (t, J=7.3 Hz, 1H), 5.33 (ddd, J=50.7, 10.2, 7.3 Hz, 2H), 4.00-3.88 (m, 2H), 2.36-2.32 (m, 3H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03, −124.66-−124.74(m); ESIMS m/z 601 ([M+H]⁺).

(Z)-1-(3-(2-Ethyl-6-methylphenyl)-4-oxothiazolidin-2-ylidene)-3-((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)urea (F30)

The title compound was isolated as a solid foam (40 mg, 53%): ¹H NMR (500 MHz, CDCl₃) δ 8.52 (s, 1H), 8.12-8.07 (m, 2H), 7.79-7.76 (m, 2H), 7.39-7.36 (m, 2H), 7.32 (t, J=7.6 Hz, 1H), 7.20 (d, J=7.7 Hz, 1H), 7.16 (d, J=7.5 Hz, 1H), 7.04-7.00 (m, 2H), 6.28 (t, J=7.2 Hz, 1H), 5.35-5.26 (m, 2H), 3.96 (s, 2H), 2.40 (q, J=7.6 Hz, 2H), 2.10 (s, 3H), 1.14 (t, J=7.6 Hz, 3H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03; ESIMS m/z 611 ([M+H]⁺).

(Z)-1-(3-(2-(1-(methylthio)ethyl)phenyl)-4-oxothiazolidin-2-ylidene)-3-((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)urea (F31)

The title compound was isolated as a white solid (46 mg, 58%): ¹H NMR (500 MHz, CDCl₃) δ 8.52 (s, 1H), 8.11-8.07 (m, 2H), 7.80-7.69 (m, 3H), 7.52-7.45 (m, 1H), 7.42-7.31 (m, 3H), 7.06-6.98 (m, 3H), 6.28-6.06 (m, 1H), 5.38-5.25 (m, 2H), 4.01-3.89 (m, 2H), 3.73-3.61 (m, 1H), 1.79-1.69 (m, 3H), 1.46-1.42 (m, 3H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.02; ESIMS m/z 643 ([M+H]⁺).

(Z)-1-(3-(4-Methoxy-2-methylphenyl)-4-oxothiazolidin-2-ylidene)-3-((4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)phenoxy)methyl)urea (F32)

The title compound was isolated as a yellow oil (24 mg, 32%): ¹H NMR (500 MHz, CDCl₃) δ 8.52 (s, 1H), 8.12-8.07 (m, 2H), 7.80-7.75 (m, 2H), 7.38 (d, J=8.6 Hz, 2H), 7.05-7.00 (m, 2H), 6.99 (d, J=8.5 Hz, 1H), 6.85-6.79 (m, 2H), 6.28 (t, J=7.2 Hz, 1H), 5.37-5.28 (m, 2H), 3.95-3.90 (m, 2H), 3.81 (s, 3H), 2.10 (s, 3H); ¹⁹F NMR (471 MHz, CDCl₃) δ −58.03; ESIMS m/z 613 ([M+H]⁺).

Biological Assays

The following bioassays against Beet Armyworm (Spodoptera exigua), Cabbage Looper (Trichoplusia ni), and Yellow Fever Mosquito (Aedes aegypti), are included herein due to the damage they inflict. Furthermore, the Beet Armyworm and Cabbage Looper are two good indicator species for a broad range of chewing pests. Additionally, the Green Peach Aphid is a good indicator species for a broad range of sap-feeding pests. The results with these four indicator species along with the Yellow Fever Mosquito show the broad usefulness of the molecules of Formula One in controlling pests in Phyla Arthropoda, Mollusca, and Nematoda (Drewes et al.)

Example A: Bioassays on Beet Armyworm (Spodoptera exigua, LAPHEG) (“BAW”) and Cabbage Looper (Trichoplusia ni, TRIPNI) (“CL”)

Beet armyworm is a serious pest of economic concern for alfalfa, asparagus, beets, citrus, corn, cotton, onions, peas, peppers, potatoes, soybeans, sugar beets, sunflowers, tobacco, and tomatoes, among other crops. It is native to Southeast Asia but is now found in Africa, Australia, Japan, North America, and Southern Europe. The larvae may feed in large swarms causing devastating crop losses. It is known to be resistant to several pesticides.

Cabbage looper is a serious pest found throughout the world. It attacks alfalfa, beans, beets, broccoli, Brussel sprouts, cabbage, cantaloupe, cauliflower, celery, collards, cotton, cucumbers, eggplant, kale, lettuce, melons, mustard, parsley, peas, peppers, potatoes, soybeans, spinach, squash, tomatoes, turnips, and watermelons, among other crops. This species is very destructive to plants due to its voracious appetite. The larvae consume three times their weight in food daily. The feeding sites are marked by large accumulations of sticky, wet, fecal material, which may contribute to higher disease pressure thereby causing secondary problems on the plants in the site. It is known to be resistant to several pesticides.

Consequently, because of the above factors control of these pests is important. Furthermore, molecules that control these pests (BAW and CL), which are known as chewing pests, will be useful in controlling other pests that chew on plants.

Certain molecules disclosed in this document were tested against BAW and CL using procedures described in the following examples. In the reporting of the results, the “BAW & CL Rating Table” was used (See Table Section).

Bioassays on BAW

Bioassays on BAW were conducted using a 128-well diet tray assay. One to five second instar BAW larvae were placed in each well (3 mL) of the diet tray that had been previously filled with 1 mL of artificial diet to which 50 μg/cm² of the test molecule (dissolved in 50 μL of 90:10 acetone-water mixture) had been applied (to each of eight wells) and then allowed to dry. Trays were covered with a clear self-adhesive cover, vented to allow gas exchange, and held at 25° C., 14:10 light-dark for five to seven days. Percent mortality was recorded for the larvae in each well; activity in the eight wells was then averaged. The results are indicated in the table entitled “Table ABC: Biological Results” (See Table Section).

Bioassays on CL

Bioassays on CL were conducted using a 128-well diet tray assay. One to five second instar CL larvae were placed in each well (3 mL) of the diet tray that had been previously filled with 1 mL of artificial diet to which 50 μg/cm² of the test molecule (dissolved in 50 μL of 90:10 acetone-water mixture) had been applied (to each of eight wells) and then allowed to dry. Trays were covered with a clear self-adhesive cover, vented to allow gas exchange, and held at 25° C., 14:10 light-dark for five to seven days. Percent mortality was recorded for the larvae in each well; activity in the eight wells was then averaged. The results are indicated in the table entitled “Table ABC: Biological Results” (See Table Section).

Example B: Bioassays on Yellow Fever Mosquito (Aedes aegypti, AEDSAE) (“YFM”)

YFM prefers to feed on humans during the daytime and is most frequently found in or near human habitations. YFM is a vector for transmitting several diseases. It is a mosquito that can spread the dengue fever and yellow fever viruses. Yellow fever is the second most dangerous mosquito-borne disease after malaria. Yellow fever is an acute viral hemorrhagic disease and up to 50% of severely affected persons without treatment will die from yellow fever. There are an estimated 200,000 cases of yellow fever, causing 30,000 deaths worldwide each year. Dengue fever is a nasty, viral disease; it is sometimes called “breakbone fever” or “break-heart fever” because of the intense pain it can produce. Dengue fever kills about 20,000 people annually. Consequently, because of the above factors control of this pest is important. Furthermore, molecules that control this pest (YFM), which is known as a sucking pest, are useful in controlling other pests that cause human and animal suffering.

Certain molecules disclosed in this document were tested against YFM using procedures described in the following paragraph. In the reporting of the results, the “YFM Rating Table” was used (See Table Section).

Master plates containing 400 μg of a molecule dissolved in 100 μL of dimethyl sulfoxide (DMSO) (equivalent to a 4000 ppm solution) are used. A master plate of assembled molecules contains 15 μL per well. To this plate, 135 μL of a 90:10 water/acetone mixture is added to each well. A robot (Biomek® NXP Laboratory Automation Workstation) is programmed to dispense 15 μL aspirations from the master plate into an empty 96-well shallow plate (“daughter” plate). There are 6 reps (“daughter” plates) created per master. The created “daughter” plates are then immediately infested with YFM larvae.

The day before plates are to be treated, mosquito eggs are placed in Millipore water containing liver powder to begin hatching (4 g into 400 mL). After the “daughter” plates are created using the robot, they are infested with 220 μL of the liver powder/larval mosquito mixture (about 1 day-old larvae). After plates are infested with mosquito larvae, a non-evaporative lid is used to cover the plate to reduce drying. Plates are held at room temperature for 3 days prior to grading. After 3 days, each well is observed and scored based on mortality. The results are indicated in the table entitled “Table ABC: Biological Results” (See Table Section).

Agriculturally Acceptable Acid Addition Salts, Salt Derivatives, Solvates, Ester Derivatives, Polymorphs, Isotopes, and Radionuclides

Molecules of Formula One may be formulated into agriculturally acceptable acid addition salts. By way of a non-limiting example, an amine function can form salts with hydrochloric, hydrobromic, sulfuric, phosphoric, acetic, benzoic, citric, malonic, salicylic, malic, fumaric, oxalic, succinic, tartaric, lactic, gluconic, ascorbic, maleic, aspartic, benzenesulfonic, methanesulfonic, ethanesulfonic, hydroxyl-methanesulfonic, and hydroxyethanesulfonic acids. Additionally, by way of a non-limiting example, an acid function can form salts including those derived from alkali or alkaline earth metals and those derived from ammonia and amines. Examples of preferred cations include sodium, potassium, and magnesium.

Molecules of Formula One may be formulated into salt derivatives. By way of a non-limiting example, a salt derivative may be prepared by contacting a free base with a sufficient amount of the desired acid to produce a salt. A free base may be regenerated by treating the salt with a suitable dilute aqueous base solution such as dilute aqueous sodium hydroxide, potassium carbonate, ammonia, and sodium bicarbonate. As an example, in many cases, a pesticide, such as 2,4-D, is made more water-soluble by converting it to its dimethylamine salt.

Molecules of Formula One may be formulated into stable complexes with a solvent, such that the complex remains intact after the non-complexed solvent is removed. These complexes are often referred to as “solvates.” However, it is particularly desirable to form stable hydrates with water as the solvent.

Molecules of Formula One containing an acid functionality may be made into ester derivatives. These ester derivatives can then be applied in the same manner as the molecules disclosed in this document are applied.

Molecules of Formula One may be made as various crystal polymorphs. Polymorphism is important in the development of agrochemicals since different crystal polymorphs or structures of the same molecule can have vastly different physical properties and biological performances.

Molecules of Formula One may be made with different isotopes. Of particular importance are molecules having ²H (also known as deuterium) or ³H (also known as tritium) in place of ¹H. Molecules of Formula One may be made with different radionuclides. Of particular importance are molecules having ¹⁴C (also known as radiocarbon). Molecules of Formula One having deuterium, tritium, or ¹⁴C may be used in biological studies allowing tracing in chemical and physiological processes and half-life studies, as well as, MoA studies.

Combinations

In another embodiment of this invention, molecules of Formula One may be used in combination (such as, in a compositional mixture, or a simultaneous or sequential application) with one or more active ingredients.

In another embodiment of this invention, molecules of Formula One may be used in combination (such as, in a compositional mixture, or a simultaneous or sequential application) with one or more active ingredients each having a MoA that is the same as, similar to, but more likely—different from, the MoA of the molecules of Formula One.

In another embodiment, molecules of Formula One may be used in combination (such as, in a compositional mixture, or a simultaneous or sequential application) with one or more molecules having acaricidal, algicidal, avicidal, bactericidal, fungicidal, herbicidal, insecticidal, molluscicidal, nematicidal, rodenticidal, and/or virucidal properties.

In another embodiment, the molecules of Formula One may be used in combination (such as, in a compositional mixture, or a simultaneous or sequential application) with one or more molecules that are antifeedants, bird repellents, chemosterilants, herbicide safeners, insect attractants, insect repellents, mammal repellents, mating disrupters, plant activators, plant growth regulators, and/or synergists.

In another embodiment, molecules of Formula One may also be used in combination (such as in a compositional mixture, or a simultaneous or sequential application) with one or more biopesticides.

In another embodiment, in a pesticidal composition combinations of a molecule of Formula One and an active ingredient may be used in a wide variety of weight ratios. For example, in a two-component mixture, the weight ratio of a molecule of Formula One to an active ingredient, the weight ratios in Table B may be used. However, in general, weight ratios less than about 10:1 to about 1:10 are preferred. It is also preferred sometimes to use a three, four, five, six, seven, or more, component mixture comprising a molecule of Formula One and an additional two or more active ingredients.

TABLE B Weight Ratios Molecule of the Formula One:active ingredient 100:1 to 1:100 50:1 to 1:50 20:1 to 1:20 10:1 to 1:10 5:1 to 1:5 3:1 to 1:3 2:1 to 1:2 1:1

Weight ratios of a molecule of Formula One to an active ingredient may also be depicted as X:Y; wherein X is the parts by weight of a molecule of Formula One and Y is the parts by weight of active ingredient. The numerical range of the parts by weight for X is 0<X≤100 and the parts by weight for Y is 0<Y≤100 and is shown graphically in TABLE C. By way of non-limiting example, the weight ratio of a molecule of Formula One to an active ingredient may be 20:1.

Ranges of weight ratios of a molecule of Formula One to an active ingredient may be depicted as X₁:Y₁ to X₂:Y₂, wherein X and Y are defined as above.

In one embodiment, the range of weight ratios may be X₁:Y₁ to X₂:Y₂, wherein X₁>Y₁ and X₂<Y₂. By way of non-limiting example, the range of a weight ratio of a molecule of Formula One to an active ingredient may be between 3:1 and 1:3, inclusive of the endpoints.

In another embodiment, the range of weight ratios may be X₁:Y₁ to X₂:Y₂, wherein X₁>Y₁ and X₂>Y₂. By way of non-limiting example, the range of weight ratio of a molecule of Formula One to an active ingredient may be between 15:1 and 3:1, inclusive of the endpoints.

In another embodiment, the range of weight ratios may be X₁:Y to X₂:Y₂, wherein X₁<Y₁ and X₂<Y₂. By way of non-limiting example, the range of weight ratios of a molecule of Formula One to an active ingredient may be between about 1:3 and about 1:20, inclusive of the endpoints.

It is envisioned that certain weight ratios of a molecule of Formula One to an active ingredient, as presented in Table B and C, may be synergistic.

TABLE C active ingredient 100 X, Y X, Y X, Y (Y) Parts by weight 50 X, Y X, Y X, Y X, Y X, Y 20 X, Y X, Y X, Y X, Y X, Y 15 X, Y X, Y X, Y X, Y X, Y 10 X, Y X, Y 5 X, Y X, Y X, Y X, Y 3 X, Y X, Y X, Y X,Y X, Y X, Y X, Y 2 X, Y X, Y X, Y X, Y X, Y 1 X, Y X, Y X, Y X, Y X,Y X, Y X, Y X, Y X, Y 1 2 3 5 10 15 20 50 100 molecule of Formula One (X) Parts by weight

Formulations

A pesticide is many times not suitable for application in its pure form. It is usually necessary to add other substances so that the pesticide may be used at the required concentration and in an appropriate form, permitting ease of application, handling, transportation, storage, and maximum pesticide activity. Thus, pesticides are formulated into, for example, baits, concentrated emulsions, dusts, emulsifiable concentrates, fumigants, gels, granules, microencapsulations, seed treatments, suspension concentrates, suspoemulsions, tablets, water soluble liquids, water dispersible granules or dry flowables, wettable powders, and ultra-low volume solutions.

Pesticides are applied most often as aqueous suspensions or emulsions prepared from concentrated formulations of such pesticides. Such water-soluble, water-suspendable, or emulsifiable formulations are either solids, usually known as wettable powders, water dispersible granules, liquids usually known as emulsifiable concentrates, or aqueous suspensions. Wettable powders, which may be compacted to form water dispersible granules, comprise an intimate mixture of the pesticide, a carrier, and surfactants. The concentration of the pesticide is usually from about 10% to about 90% by weight. The carrier is usually selected from among the attapulgite clays, the montmorillonite clays, the diatomaceous earths, or the purified silicates. Effective surfactants, comprising from about 0.5% to about 10% of the wettable powder, are found among sulfonated lignins, condensed naphthalenesulfonates, naphthalenesulfonates, alkylbenzenesulfonates, alkyl sulfates, and non-ionic surfactants such as ethylene oxide adducts of alkyl phenols.

Emulsifiable concentrates of pesticides comprise a convenient concentration of a pesticide, such as from about 50 to about 500 grams per liter of liquid dissolved in a carrier that is either a water miscible solvent or a mixture of water-immiscible organic solvent and emulsifiers. Useful organic solvents include aromatics, especially xylenes and petroleum fractions, especially the high-boiling naphthalenic and olefinic portions of petroleum such as heavy aromatic naphtha. Other organic solvents may also be used, such as the terpenic solvents including rosin derivatives, aliphatic ketones such as cyclohexanone, and complex alcohols such as 2-ethoxyethanol. Suitable emulsifiers for emulsifiable concentrates are selected from conventional anionic and non-ionic surfactants.

Aqueous suspensions comprise suspensions of water-insoluble pesticides dispersed in an aqueous carrier at a concentration in the range from about 5% to about 50% by weight. Suspensions are prepared by finely grinding the pesticide and vigorously mixing it into a carrier comprised of water and surfactants. Ingredients, such as inorganic salts and synthetic or natural gums may, also be added to increase the density and viscosity of the aqueous carrier. It is often most effective to grind and mix the pesticide at the same time by preparing the aqueous mixture and homogenizing it in an implement such as a sand mill, ball mill, or piston-type homogenizer. The pesticide in suspension might be microencapsulated in plastic polymer.

Oil dispersions (OD) comprise suspensions of organic solvent-insoluble pesticides finely dispersed in a mixture of organic solvent and emulsifiers at a concentration in the range from about 2% to about 50% by weight. One or more pesticide might be dissolved in the organic solvent. Useful organic solvents include aromatics, especially xylenes and petroleum fractions, especially the high-boiling naphthalenic and olefinic portions of petroleum such as heavy aromatic naphtha. Other solvents may include vegetable oils, seed oils, and esters of vegetable and seed oils. Suitable emulsifiers for oil dispersions are selected from conventional anionic and non-ionic surfactants. Thickeners or gelling agents are added in the formulation of oil dispersions to modify the rheology or flow properties of the liquid and to prevent separation and settling of the dispersed particles or droplets.

Pesticides may also be applied as granular compositions that are particularly useful for applications to the soil. Granular compositions usually contain from about 0.5% to about 10% by weight of the pesticide, dispersed in a carrier that comprises clay or a similar substance. Such compositions are usually prepared by dissolving the pesticide in a suitable solvent and applying it to a granular carrier, which has been pre-formed to the appropriate particle size, in the range of from about 0.5 mm to about 3 mm. Such compositions may also be formulated by making a dough or paste of the carrier and molecule, and then crushing and drying to obtain the desired granular particle size. Another form of granules is a water emulsifiable granule (EG). It is a formulation consisting of granules to be applied as a conventional oil-in-water emulsion of the active ingredient(s), either solubilized or diluted in an organic solvent, after disintegration and dissolution in water. Water emulsifiable granules comprise one or several active ingredient(s), either solubilized or diluted in a suitable organic solvent that is (are) absorbed in a water soluble polymeric shell or some other type of soluble or insoluble matrix.

Dusts containing a pesticide are prepared by intimately mixing the pesticide in powdered form with a suitable dusty agricultural carrier, such as kaolin clay, ground volcanic rock, and the like. Dusts can suitably contain from about 1% to about 10% of the pesticide. Dusts may be applied as a seed dressing or as a foliage application with a dust blower machine.

It is equally practical to apply a pesticide in the form of a solution in an appropriate organic solvent, usually petroleum oil, such as the spray oils, which are widely used in agricultural chemistry.

Pesticides can also be applied in the form of an aerosol composition. In such compositions, the pesticide is dissolved or dispersed in a carrier, which is a pressure-generating propellant mixture. The aerosol composition is packaged in a container from which the mixture is dispensed through an atomizing valve.

Pesticide baits are formed when the pesticide is mixed with food or an attractant or both. When the pests eat the bait, they also consume the pesticide. Baits may take the form of granules, gels, flowable powders, liquids, or solids. Baits may be used in pest harborages.

Fumigants are pesticides that have a relatively high vapor pressure and hence can exist as a gas in sufficient concentrations to kill pests in soil or enclosed spaces. The toxicity of the fumigant is proportional to its concentration and the exposure time. They are characterized by a good capacity for diffusion and act by penetrating the pest's respiratory system or being absorbed through the pest's cuticle. Fumigants are applied to control stored product pests under gas proof sheets, in gas sealed rooms or buildings, or in special chambers.

Pesticides may be microencapsulated by suspending the pesticide particles or droplets in plastic polymers of various types. By altering, the chemistry of the polymer or by changing factors in the processing, microcapsules may be formed of various sizes, solubility, wall thicknesses, and degrees of penetrability. These factors govern the speed with which the active ingredient within is released, which in turn, affects the residual performance, speed of action, and odor of the product. The microcapsules might be formulated as suspension concentrates or water dispersible granules.

Oil solution concentrates are made by dissolving pesticide in a solvent that will hold the pesticide in solution. Oil solutions of a pesticide usually provide faster knockdown and kill of pests than other formulations due to the solvents themselves having pesticidal action and the dissolution of the waxy covering of the integument increasing the speed of uptake of the pesticide. Other advantages of oil solutions include better storage stability, better penetration of crevices, and better adhesion to greasy surfaces.

Another embodiment is an oil-in-water emulsion, wherein the emulsion comprises oily globules which are each provided with a lamellar liquid crystal coating and are dispersed in an aqueous phase, wherein each oily globule comprises at least one molecule which is agriculturally active, and is individually coated with a monolamellar or oligolamellar layer comprising: (1) at least one non-ionic lipophilic surface-active agent, (2) at least one non-ionic hydrophilic surface-active agent, and (3) at least one ionic surface-active agent, wherein the globules having a mean particle diameter of less than 800 nanometers.

Other Formulation Components

Generally, when the molecules disclosed in Formula One are used in a formulation, such formulation can also contain other components. These components include, but are not limited to, (this is a non-exhaustive and non-mutually exclusive list) wetters, spreaders, stickers, penetrants, buffers, sequestering agents, drift reduction agents, compatibility agents, anti-foam agents, cleaning agents, and emulsifiers. A few components are described forthwith.

A wetting agent is a substance that when added to a liquid increases the spreading or penetration power of the liquid by reducing the interfacial tension between the liquid and the surface on which it is spreading. Wetting agents are used for two main functions in agrochemical formulations: during processing and manufacture to increase the rate of wetting of powders in water to make concentrates for soluble liquids or suspension concentrates; and during mixing of a product with water in a spray tank to reduce the wetting time of wettable powders and to improve the penetration of water into water-dispersible granules. Examples of wetting agents used in wettable powder, suspension concentrate, and water-dispersible granule formulations are: sodium lauryl sulfate, sodium dioctyl sulfosuccinate, alkyl phenol ethoxylates, and aliphatic alcohol ethoxylates.

A dispersing agent is a substance that adsorbs onto the surface of particles, helps to preserve the state of dispersion of the particles, and prevents them from reaggregating. Dispersing agents are added to agrochemical formulations to facilitate dispersion and suspension during manufacture, and to ensure the particles redisperse into water in a spray tank. They are widely used in wettable powders, suspension concentrates, and water-dispersible granules. Surfactants that are used as dispersing agents have the ability to adsorb strongly onto a particle surface and provide a charged or steric barrier to reaggregation of particles. The most commonly used surfactants are anionic, non-ionic, or mixtures of the two types. For wettable powder formulations, the most common dispersing agents are sodium lignosulfonates. For suspension concentrates, very good adsorption and stabilization are obtained using polyelectrolytes, such as sodium-naphthalene-sulfonate-formaldehyde-condensates. Tristyrylphenol ethoxylate phosphate esters are also used. Non-ionics such as alkylarylethylene oxide condensates and EO-PO block copolymers are sometimes combined with anionics as dispersing agents for suspension concentrates. In recent years, new types of very high molecular weight polymeric surfactants have been developed as dispersing agents. These have very long hydrophobic ‘backbones’ and a large number of ethylene oxide chains forming the ‘teeth’ of a ‘comb’ surfactant. These high molecular weight polymers can give very good long-term stability to suspension concentrates because the hydrophobic backbones have many anchoring points onto the particle surfaces. Examples of dispersing agents used in agrochemical formulations are: sodium lignosulfonates, sodium naphthalene sulfonate formaldehyde condensates, tristyrylphenol-ethoxylate-phosphate-esters, aliphatic alcohol ethoxylates, alkyl ethoxylates, EO-PO block copolymers, and graft copolymers.

An emulsifying agent is a substance that stabilizes a suspension of droplets of one liquid phase in another liquid phase. Without the emulsifying agent, the two liquids would separate into two immiscible liquid phases. The most commonly used emulsifier blends contain an alkylphenol or an aliphatic alcohol with twelve or more ethylene oxide units and the oil-soluble calcium salt of dodecylbenzenesulfonic acid. A range of hydrophile-lipophile balance (“HLB”) values from about 8 to about 18 will normally provide good stable emulsions. Emulsion stability can sometimes be improved by the addition of a small amount of an EO-PO block copolymer surfactant.

A solubilizing agent is a surfactant that will form micelles in water at concentrations above the critical micelle concentration. The micelles are then able to dissolve or solubilize water-insoluble materials inside the hydrophobic part of the micelle. The types of surfactants usually used for solubilization are non-ionics, sorbitan monooleates, sorbitan monooleate ethoxylates, and methyl oleate esters.

Surfactants are sometimes used, either alone or with other additives such as mineral or vegetable oils as adjuvants to spray-tank mixes to improve the biological performance of the pesticide on the target. The types of surfactants used for bioenhancement depend generally on the nature and mode of action of the pesticide. However, they are often non-ionics such as: alkyl ethoxylates, linear aliphatic alcohol ethoxylates, and aliphatic amine ethoxylates.

A carrier or diluent in an agricultural formulation is a material added to the pesticide to give a product of the required strength. Carriers are usually materials with high absorptive capacities, while diluents are usually materials with low absorptive capacities. Carriers and diluents are used in the formulation of dusts, wettable powders, granules, and water-dispersible granules.

Organic solvents are used mainly in the formulation of emulsifiable concentrates, oil-in-water emulsions, suspoemulsions, oil dispersions, and ultra-low volume formulations, and to a lesser extent, granular formulations. Sometimes mixtures of solvents are used. The first main groups of solvents are aliphatic paraffinic oils such as kerosene or refined paraffins. The second main group (and the most common) comprises the aromatic solvents such as xylene and higher molecular weight fractions of C9 and C10 aromatic solvents. Chlorinated hydrocarbons are useful as cosolvents to prevent crystallization of pesticides when the formulation is emulsified into water. Alcohols are sometimes used as cosolvents to increase solvent power. Other solvents may include vegetable oils, seed oils, and esters of vegetable and seed oils.

Thickeners or gelling agents are used mainly in the formulation of suspension concentrates, oil dispersions, emulsions and suspoemulsions to modify the rheology or flow properties of the liquid and to prevent separation and settling of the dispersed particles or droplets. Thickening, gelling, and anti-settling agents generally fall into two categories, namely water-insoluble particulates and water-soluble polymers. It is possible to produce suspension concentrate and oil dispersion formulations using clays and silicas. Examples of these types of materials, include, but are not limited to, montmorillonite, bentonite, magnesium aluminum silicate, and attapulgite. Water-soluble polysaccharides in water based suspension concentrates have been used as thickening-gelling agents for many years. The types of polysaccharides most commonly used are natural extracts of seeds and seaweeds or are synthetic derivatives of cellulose. Examples of these types of materials include, but are not limited to, guar gum, locust bean gum, carrageenam, alginates, methyl cellulose, sodium carboxymethyl cellulose (SCMC), and hydroxyethyl cellulose (HEC). Other types of anti-settling agents are based on modified starches, polyacrylates, polyvinyl alcohol, and polyethylene oxide. Another good anti-settling agent is xanthan gum.

Microorganisms can cause spoilage of formulated products. Therefore, preservation agents are used to eliminate or reduce their effect. Examples of such agents include, but are not limited to: propionic acid and its sodium salt, sorbic acid and its sodium or potassium salts, benzoic acid and its sodium salt, p-hydroxybenzoic acid sodium salt, methyl p-hydroxybenzoate, and 1,2-benzisothiazolin-3-one (BIT).

The presence of surfactants often causes water-based formulations to foam during mixing operations in production and in application through a spray tank. In order to reduce the tendency to foam, anti-foam agents are often added either during the production stage or before filling into bottles. Generally, there are two types of anti-foam agents, namely silicones and non-silicones. Silicones are usually aqueous emulsions of dimethyl polysiloxane, while the non-silicone anti-foam agents are water-insoluble oils, such as octanol and nonanol, or silica. In both cases, the function of the anti-foam agent is to displace the surfactant from the air-water interface.

“Green” agents (e.g., adjuvants, surfactants, solvents) can reduce the overall environmental footprint of crop protection formulations. Green agents are biodegradable and generally derived from natural and/or sustainable sources, e.g. plant and animal sources. Specific examples are: vegetable oils, seed oils, and esters thereof, also alkoxylated alkyl polyglucosides.

Applications

Molecules of Formula One may be applied to any locus. Particular loci to apply such molecules include loci where alfalfa, almonds, apples, barley, beans, canola, corn, cotton, crucifers, flowers, fodder species (Rye Grass, Sudan Grass, Tall Fescue, Kentucky Blue Grass, and Clover), fruits, lettuce, oats, oil seed crops, oranges, peanuts, pears, peppers, potatoes, rice, sorghum, soybeans, strawberries, sugarcane, sugarbeets, sunflowers, tobacco, tomatoes, wheat (for example, Hard Red Winter Wheat, Soft Red Winter Wheat, White Winter Wheat, Hard Red Spring Wheat, and Durum Spring Wheat), and other valuable crops are growing or the seeds thereof are going to be planted.

Molecules of Formula One may also be applied where plants, such as crops, are growing and where there are low levels (even no actual presence) of pests that can commercially damage such plants. Applying such molecules in such locus is to benefit the plants being grown in such locus. Such benefits, may include, but are not limited to: helping the plant grow a better root system; helping the plant better withstand stressful growing conditions; improving the health of a plant; improving the yield of a plant (e.g. increased biomass and/or increased content of valuable ingredients); improving the vigor of a plant (e.g. improved plant growth and/or greener leaves); improving the quality of a plant (e.g. improved content or composition of certain ingredients); and improving the tolerance to abiotic and/or biotic stress of the plant.

Molecules of Formula One may be applied with ammonium sulfate when growing various plants as this may provide additional benefits.

Molecules of Formula One may be applied on, in, or around plants genetically modified to express specialized traits, such as Bacillus thuringiensis (for example, Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1/Cry35Ab1), other insecticidal toxins, or those expressing herbicide tolerance, or those with “stacked” foreign genes expressing insecticidal toxins, herbicide tolerance, nutrition-enhancement, or any other beneficial traits.

Molecules of Formula One may be applied to the foliar and/or fruiting portions of plants to control pests. Either such molecules will come in direct contact with the pest, or the pest will consume such molecules when eating the plant or while extracting sap or other nutrients from the plant.

Molecules of Formula One may also be applied to the soil, and when applied in this manner, root and stem feeding pests may be controlled. The roots may absorb such molecules thereby taking it up into the foliar portions of the plant to control above ground chewing and sap feeding pests.

Systemic movement of pesticides in plants may be utilized to control pests on one portion of the plant by applying (for example by spraying a locus) a molecule of Formula One to a different portion of the plant. For example, control of foliar-feeding insects may be achieved by drip irrigation or furrow application, by treating the soil with for example pre- or post-planting soil drench, or by treating the seeds of a plant before planting.

Molecules of Formula One may be used with baits. Generally, with baits, the baits are placed in the ground where, for example, termites can come into contact with, and/or be attracted to, the bait. Baits can also be applied to a surface of a building, (horizontal, vertical, or slant surface) where, for example, ants, termites, cockroaches, and flies, can come into contact with, and/or be attracted to, the bait.

Molecules of Formula One may be encapsulated inside, or placed on the surface of a capsule. The size of the capsules can range from nanometer size (about 100-900 nanometers in diameter) to micrometer size (about 10-900 microns in diameter).

Molecules of Formula One may be applied to eggs of pests. Because of the unique ability of the eggs of some pests to resist certain pesticides, repeated applications of such molecules may be desirable to control newly emerged larvae.

Molecules of Formula One may be applied as seed treatments. Seed treatments may be applied to all types of seeds, including those from which plants genetically modified to express specialized traits will germinate. Representative examples include those expressing proteins toxic to invertebrate pests, such as Bacillus thuringiensis or other insecticidal toxins, those expressing herbicide tolerance, such as “Roundup Ready” seed, or those with “stacked” foreign genes expressing insecticidal toxins, herbicide tolerance, nutrition-enhancement, drought tolerance, or any other beneficial traits. Furthermore, such seed treatments with molecules of Formula One may further enhance the ability of a plant to withstand stressful growing conditions better. This results in a healthier, more vigorous plant, which can lead to higher yields at harvest time. Generally, about 1 gram of such molecules to about 500 grams per 100,000 seeds is expected to provide good benefits, amounts from about 10 grams to about 100 grams per 100,000 seeds is expected to provide better benefits, and amounts from about 25 grams to about 75 grams per 100,000 seeds is expected to provide even better benefits. Molecules of Formula One may be applied with one or more active ingredients in a soil amendment.

Molecules of Formula One may be used for controlling endoparasites and ectoparasites in the veterinary medicine sector or in the field of non-human-animal keeping. Such molecules may be applied by oral administration in the form of, for example, tablets, capsules, drinks, granules, by dermal application in the form of, for example, dipping, spraying, pouring on, spotting on, and dusting, and by parenteral administration in the form of, for example, an injection.

Molecules of Formula One may also be employed advantageously in livestock keeping, for example, cattle, chickens, geese, goats, pigs, sheep, and turkeys. They may also be employed advantageously in pets such as, horses, dogs, and cats. Particular pests to control would be flies, fleas, and ticks that are bothersome to such animals. Suitable formulations are administered orally to the animals with the drinking water or feed. The dosages and formulations that are suitable depend on the species.

Molecules of Formula One may also be used for controlling parasitic worms, especially of the intestine, in the animals listed above.

Molecules of Formula One may also be employed in therapeutic methods for human health care. Such methods include, but are limited to, oral administration in the form of, for example, tablets, capsules, drinks, granules, and by dermal application.

Molecules of Formula One may also be applied to invasive pests. Pests around the world have been migrating to new environments (for such pest) and thereafter becoming a new invasive species in such new environment. Such molecules may also be used on such new invasive species to control them in such new environments.

Molecules according to Formula One may be tested to determine its efficacy against pests. Additionally, a molecule of Formula One may be mixed with another active ingredient to form a pesticidal composition, and then that composition is tested to determine if it is synergistic using conventional testing procedures. Furthermore, mode of action studies may be conducted to determine if said molecule has a different mode of action than other pesticides. Thereafter, such acquired data may be disseminated, such as by the internet, to third parties.

BAW & CL Rating Table % Control (or Mortality) Rating 50-100 A More than 0 - Less than 50 B Not Tested C No activity noticed in this bioassay D

YFM Rating Table % Control (or Mortality) Rating 80-100 A More than 0 - Less than 80 B Not Tested C No activity noticed in this bioassay D

TABLE ABC Biological Results Cmpd No BAW CL YFM F1  A A C F2  A A C F3  C C C F4  C C C F5  C C C F6  C C C F7  C C C F8  C C C F9  C C C F10 C C C F11 C C C F12 C C C F13 C C C F14 C C C F15 C C C F16 C C C F17 C C C F18 C C C F19 C C C F20 C C C F21 C C C F22 C C C F23 A A C F24 A A C F25 A A C F26 D A C F27 A A C F28 D B C F29 A A C F30 A A C F31 A A C F32 A A C 

We claim:
 1. A molecule having the structure of Formula One:

wherein: (A) Ar¹ is selected from the group consisting of furanyl, phenyl, pyridazinyl, pyridyl, pyrimidinyl, or thienyl, wherein each furanyl, phenyl, pyridazinyl, pyridyl, pyrimidinyl, and thienyl may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy, wherein each alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy substituent may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy; (B) Het is a 5- or 6-membered, saturated or unsaturated, heterocyclic ring, containing one or more heteroatoms independently selected from nitrogen, sulfur, or oxygen, and where Ar¹ and Ar² are not ortho to each other, but may be meta or para, for example, for a five-membered ring they are 1,3, and for a 6-membered ring they are either 1,3 or 1,4, wherein each heterocyclic ring may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, oxo, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₆8alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy, wherein each alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy substituent may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy; (C) L¹ is selected from the group consisting of O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, O—(C₁-C₈)haloalkyl, O—(C₃-C₈)cycloalkyl, O—(C₁-C₈)haloalkoxy, O—(C₂-C₈)alkenyl, and O—(C₂-C₈)alkynyl, wherein each alkyl, haloalkyl, cycloalkyl, alkenyl, and alkynyl may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, and (C₂-C₈)alkynyl; (D) Ar² is selected from the group consisting of furanyl, phenyl, pyridazinyl, pyridyl, pyrimidinyl, or thienyl, and where Het and L¹ are not ortho to each other, but may be meta or para, for example, for a five-membered ring they are 1,3, and for a 6-membered ring they are either 1,3 or 1,4, wherein each furanyl, phenyl, pyridazinyl, pyridyl, pyrimidinyl, and thienyl may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy, wherein each alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy substituent may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy; (E) R¹⁵ is selected from the group consisting of H, (C₁-C₈)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, C(O)—NR^(x)R^(y), C(O)-phenyl, (C₁-C₈)alkyl-NR^(x)R^(y), C(O)O—(C₁-C₈)alkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)O—(C₁-C₈)alkyl, wherein each alkyl, cycloalkyl, alkenyl, alkynyl, and phenyl may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, oxo, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy; (F) Q¹ is selected from the group consisting of O and S; (G) Q² is selected from the group consisting of O and S; (H) R¹⁶ is selected from the group consisting of (K), H, (C₁-C₈)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, C(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, (C₁-C₈)alkylphenyl, (C₁-C₈)alkyl-O-phenyl, C(O)-(Het-1), (Het-1), (C₁-C₈)alkyl-(Het-1), (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)—NR^(x)R^(y), (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-(Het-1), (C₁-C₈)alkyl-C(O)-(Het-1), (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl(NR^(x)R^(y))—C(O)OH, (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-NR^(x)R^(y), (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-N(R^(x))—C(O)O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl(N(R^(x))—C(O)O—(C₁-C₈)alkyl)-C(O)OH, (C₁-C₈)alkyl-C(O)-(Het-1)-C(O)O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)—(C₃-C₈)cycloalkyl, (C₁-C₈)alkyl-OC(O)-(Het-1), (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl-N(R^(x))—C(O)O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-NR^(x)R^(y), (C₁-C₈)alkyl-S(O)_(n)-(Het-1), and (C₁-C₈)alkyl-O-(Het-1), wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, and (Het-1) may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)OH, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl), phenyl, phenoxy, Si((C₁-C₈)alkyl)₃, S(O)_(n)—NR^(x)R^(y), and (Het-1); (I) R¹⁷ is selected from the group consisting of (K), H, (C₁-C₈)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, C(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, (C₁-C₈)alkylphenyl, (C₁-C₈)alkyl-O-phenyl, C(O)-(Het-1), (Het-1), (C₁-C₈)alkyl-(Het-1), (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)—NR^(x)R^(y), (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-(Het-1), (C₁-C₈)alkyl-C(O)-(Het-1), (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl(NR^(x)R^(y))—C(O)OH, (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-NR^(x)R^(y), (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl-N(R^(x))—C(O)O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-C(O)—N(R^(x))(C₁-C₈)alkyl(N(R^(x))—C(O)O—(C₁-C₈)alkyl)-C(O)OH, (C₁-C₈)alkyl-C(O)-(Het-1)-C(O)O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-OC(O)—(C₃-C₈)cycloalkyl, (C₁-C₈)alkyl-OC(O)-(Het-1), (C₁-C₈)alkyl-OC(O)—(C₁-C₈)alkyl-N(R^(x))—C(O)O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-NR^(x)R^(y), (C₁-C₈)alkyl-S(O)_(n)-(Het-1), and (C₁-C₈)alkyl-O-(Het-1), wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, and (Het-1) may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)OH, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, phenoxy, Si((C₁-C₈)alkyl)₃, S(O)_(n)—NR^(x)R^(y), and (Het-1); (J) L² is selected from the group consisting of (C₃-C₈)cycloalkyl, phenyl, (C₃-C₁₂)cycloalkenyl, (C₁-C₈)alkylphenyl, (C₁-C₈)alkyl-O-phenyl, (C₂-C₈)alkenyl-O-phenyl, (Het-1), (C₁-C₈)alkyl-(Het-1), and (C₁-C₈)alkyl-O-(Het-1), wherein each alkyl, cycloalkyl, alkenyl, phenyl, and (Het-1) may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₁-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, O—(C₁-C₈)alkyl, S—(C₁-C₈)alkyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, phenoxy, and (Het-1); (K) R¹⁶ and R¹⁷ along with C^(x)(Q²)(N^(x)), form a 4- to 7-membered saturated or unsaturated, heterocyclic ring, which may further contain one or more heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen, wherein each heterocyclic ring may be optionally substituted with one or more substituents independently selected from the group consisting of oxo, R¹⁸, and R¹⁹, wherein R¹⁸ and R¹⁹ are each independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), oxo, thioxo, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and (Het-1); (L) R^(x) and R^(y) are each independently selected from the group consisting of H, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, and phenyl, wherein each alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, and phenyl may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)H, C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and (Het-1); (M) (Het-1) is a 5- or 6-membered, saturated or unsaturated, heterocyclic ring, containing one or more heteroatoms independently selected from the group consisting of nitrogen, sulfur, or oxygen, wherein each heterocyclic ring may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, oxo, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy, wherein each alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy substituent may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₈)alkyl, (C₁-C₈)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₈)alkoxy, (C₁-C₈)haloalkoxy, (C₂-C₈)alkenyl, (C₂-C₈)alkynyl, S(O)_(n)—(C₁-C₈)alkyl, S(O)_(n)—(C₁-C₈)haloalkyl, OSO₂—(C₁-C₈)alkyl, OSO₂—(C₁-C₈)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₈)alkyl-NR^(x)R^(y), C(O)—(C₁-C₈)alkyl, C(O)O—(C₁-C₈)alkyl, C(O)—(C₁-C₈)haloalkyl, C(O)O—(C₁-C₈)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₈)alkenyl, C(O)O—(C₂-C₈)alkenyl, (C₁-C₈)alkyl-O—(C₁-C₈)alkyl, (C₁-C₈)alkyl-S(O)_(n)—(C₁-C₈)alkyl, C(O)—(C₁-C₈)alkyl-C(O)O—(C₁-C₈)alkyl, phenyl, and phenoxy; (N) n are each independently 0, 1, or 2; and N-oxides, agriculturally acceptable acid addition salts, salt derivatives, solvates, crystal polymorphs, isotopes, resolved stereoisomers, and tautomers, of the molecules of Formula One.
 2. The molecule according to claim 1 wherein: (A) Ar¹ is (1a)

wherein, R¹, R², R³, R⁴, and R⁵ are each independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy, wherein each alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy; (B) Het is (1b)

wherein, R⁶ is selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy, wherein each alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy; (C) L¹ is

wherein R⁷, R⁸, R⁹, and R¹⁰ are each independently selected from the group consisting of H, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, and (C₂-C₆)alkynyl; (D) Ar² is (1e)

wherein: (1) X¹ is selected from the group consisting of N and CR¹³, (2) X² is selected from the group consisting of N and CR¹⁴, and (3) R¹¹, R¹², R¹³, and R¹⁴ are each independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy, wherein each alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy; (E) R¹⁵ is selected from the group consisting of H, (C₁-C₄)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, C(O)—NR^(x)R^(y), C(O)-phenyl, (C₁-C₄)alkyl-NR^(x)R^(y), C(O)O—(C₁-C₄)alkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)O—(C₁-C₄)alkyl, wherein each alkyl, cycloalkyl, alkenyl, alkynyl, and phenyl may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, oxo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy; (F) Q¹ is selected from the group consisting of O and S; (G) Q² is selected from the group consisting of O and S; (H) R¹⁶ is selected from the group consisting of (K), H, (C₁-C₄)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, C(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, (C₁-C₄)alkylphenyl, (C₁-C₄)alkyl-O-phenyl, C(O)-(Het-1), (Het-1), (C₁-C₄)alkyl-(Het-1), (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)—NR^(x)R^(y), (C₁-C₄)alkyl-C(O)—N(C₁-C₄)alkyl-C(O)-(Het-1), (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl(NR^(x)R^(y))—C(O)OH, (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-NR^(x)R^(y), (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-N(R^(x))—C(O)O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl(N(R^(x))—C(O)O—(C₁-C₄)alkyl)-C(O)OH, (C₁-C₄)alkyl-C(O)-(Het-1)-C(O)O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)—(C₃-C₈)cycloalkyl, (C₁-C₄)alkyl-OC(O)-(Het-1), (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl-N(R^(x))—C(O)O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-NR^(x)R^(y), (C₁-C₄)alkyl-S(O)_(n)-(Het-1), and (C₁-C₄)alkyl-O-(Het-1), wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, and (Het-1) may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)OH, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl), phenyl, phenoxy, Si((C₁-C₄)alkyl)₃, S(O)_(n)—NR^(x)R^(y), and (Het-1); (I) R¹⁷ is selected from the group consisting of (K), H, (C₁-C₄)alkyl, (C₃-C₈)cycloalkyl, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, C(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, (C₁-C₄)alkylphenyl, (C₁-C₄)alkyl-O-phenyl, C(O)-(Het-1), (Het-1), (C₁-C₄)alkyl-(Het-1), (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)—NR^(x)R^(y), (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-(Het-1), (C₁-C₄)alkyl-C(O)-(Het-1), (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl(NR^(x)R^(y))—C(O)OH, (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-NR^(x)R^(y), (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl-N(R^(x))—C(O)O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-C(O)—N(R^(x))(C₁-C₄)alkyl(N(R^(x))—C(O)O—(C₁-C₄)alkyl)-C(O)OH, (C₁-C₄)alkyl-C(O)-(Het-1)-C(O)O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-OC(O)—(C₃-C₈)cycloalkyl, (C₁-C₄)alkyl-OC(O)-(Het-1), (C₁-C₄)alkyl-OC(O)—(C₁-C₄)alkyl-N(R^(x))—C(O)O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-NR^(x)R^(y), (C₁-C₄)alkyl-S(O)_(n)-(Het-1), and (C₁-C₄)alkyl-O-(Het-1), wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, and (Het-1) may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)OH, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, phenoxy, Si((C₁-C₄)alkyl)₃, S(O)_(n)—NR^(x)R^(y), and (Het-1); (J) L² is (1f)

wherein, R²⁰, R²¹, R²², R²³, and R²⁴ are each independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, O—(C₁-C₄)alkyl, S—(C₁-C₄)alkyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, phenoxy, (Het-1), (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S—(C₁-C₄)alkyl, and optionally R²⁰ and R²¹ together form a (C₃-C₈)cycloalkyl, wherein each alkyl, cycloalkyl, alkenyl, phenyl, and (Het-1) substituent may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, O—(C₁-C₄)alkyl, S—(C₁-C₄)alkyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, phenoxy, and (Het-1); (K) R¹⁶ and R¹⁷ along with C^(x)(Q²)(N^(x)), is (1g)

wherein, R¹⁸ and R¹⁹ are each independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), oxo, thioxo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and (Het-1); (L) R^(x) and R^(y) are each independently selected from the group consisting of H, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, and phenyl, wherein each alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, and phenyl may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)H, C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and (Het-1); (M) (Het-1) is a 5- or 6-membered, saturated or unsaturated, heterocyclic ring, containing one or more heteroatoms independently selected from the group consisting of nitrogen, sulfur, or oxygen, wherein each heterocyclic ring may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, oxo, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy, wherein each alkyl, haloalkyl, cycloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, phenyl, and phenoxy substituent may be optionally substituted with one or more substituents independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, (C₁-C₄)alkyl, (C₁-C₄)haloalkyl, (C₃-C₈)cycloalkyl, (C₁-C₄)alkoxy, (C₁-C₄)haloalkoxy, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, S(O)_(n)—(C₁-C₄)alkyl, S(O)_(n)—(C₁-C₄)haloalkyl, OSO₂—(C₁-C₄)alkyl, OSO₂—(C₁-C₄)haloalkyl, C(O)—NR^(x)R^(y), (C₁-C₄)alkyl-NR^(x)R^(y), C(O)—(C₁-C₄)alkyl, C(O)O—(C₁-C₄)alkyl, C(O)—(C₁-C₄)haloalkyl, C(O)O—(C₁-C₄)haloalkyl, C(O)—(C₃-C₈)cycloalkyl, C(O)O—(C₃-C₈)cycloalkyl, C(O)—(C₂-C₆)alkenyl, C(O)O—(C₂-C₆)alkenyl, (C₁-C₄)alkyl-O—(C₁-C₄)alkyl, (C₁-C₄)alkyl-S(O)_(n)—(C₁-C₄)alkyl, C(O)—(C₁-C₄)alkyl-C(O)O—(C₁-C₄)alkyl, phenyl, and phenoxy; and (N) n are each independently 0, 1, or
 2. 3. The molecule according to claim 1 wherein: (A) Ar¹ is (1a)

wherein, R¹, R², R³, R⁴, and R⁵ are each independently selected from the group consisting of H, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy, and (C₁-C₆)haloalkoxy; (B) Het is (1b)

wherein, R⁶ is H; (C) L¹ is

wherein R⁸ and R¹⁰ are each independently selected from the group consisting of H, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy and (C₁-C₆)haloalkoxy; (D) Ar² is (1e)

wherein: (1) X¹ is selected from the group consisting of N and CR¹³, (2) X² is selected from the group consisting of N and CR¹⁴, and (3) R¹¹, R¹², R¹³, and R¹⁴ are each independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, phenyl, (C₁-C₆)alkoxy, and (C₁-C₆)haloalkoxy; (E) R¹⁵ is H, (C₁-C₆)alkyl or (C₂-C₆)alkenyl, wherein said alkyl is optionally substituted with a (C₃-C₆)cycloalkyl or (C₁-C₆)alkoxy; (F) Q¹ is selected from the group consisting of O and S; (G) Q² is selected from the group consisting of O and S; (H) R¹⁶ is (K), H, or (C₁-C₆)alkyl; (I) R¹⁷ is (K), H, or (C₁-C₆)alkyl; (J) L² is (1f)

wherein, R²⁰, R²¹, R²², R²³, and R²⁴ are each independently selected from the group consisting of H, F, Cl, Br, I, CN, NO₂, NR^(x)R^(y), (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, phenyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, (C₁-C₆)alkyl-O—(C₁-C₆)alkyl, (C₁-C₆)alkyl-S(O)_(n)—(C₁-C₆)alkyl, (C₁-C₆)alkyl-S—(C₁-C₆)alkyl, and optionally R²⁰ and R²¹ together form a (C₃-C₈)cycloalkyl; and (K) R¹⁶ and R¹⁷ along with C^(x)(Q²)(N^(x)), form a 4- to 7-membered saturated or unsaturated, heterocyclic ring, which may further contain one or more heteroatoms selected from the group consisting of nitrogen, sulfur, and oxygen, wherein each heterocyclic ring may be optionally substituted with one or more substituents independently selected from the group consisting of oxo, R¹⁸, and R¹⁹, wherein R¹⁸ and R¹⁹ are each independently selected from the group consisting of H, F, Cl, Br, I, CN, OH, NO₂, NR^(x)R^(y), (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₁-C₆)alkoxy, (C₁-C₆)haloalkoxy, phenyl, and oxo; (L) R^(x) and R^(y) are independently selected from H, (C₁-C₆)alkyl, (C₁-C₆)haloalkyl, (C₃-C₆)cycloalkyl, (C₃-C₆)halocycloalkyl, (C₂-C₆)alkenyl, (C₂-C₆)alkynyl, and phenyl; and (N) n are each independently 0, 1, or
 2. 4. The molecule according to claim 1 wherein: (A) Ar¹ is (1a)

wherein, R¹, R², R³, R⁴, and R⁵ are each independently selected from the group consisting of H, CH₃, CF₃, OCH₃, OCF₃, OC₂H₅, and OC₂F₅; (B) Het is (1b)

wherein, R⁶ is H; (C) L¹ is

wherein R⁸ and R¹⁰ are each independently selected from the group consisting of H, CH₃, CF₃, OCH₃, OCF₃, OC₂H₅, and OC₂F₅; (D) Ar² is (1e)

wherein: (1) X¹ is selected from the group consisting of N and CR¹³, (2) X² is selected from the group consisting of N and CR¹⁴, and (3) R¹¹, R¹², R¹³, and R¹⁴ are each independently selected from the group consisting of H, F, Cl, CH₃, CF₃, OCH₃, OCF₃, OC₂H₅, and OC₂F₅; (E) R¹⁵ is H or CH₃; (F) Q¹ is O; (G) Q² is S; (H) R¹⁶ is (K); (I) R¹⁷ is (K); (J) L² is (1f)

wherein, R²⁰, R²¹, R²², R²³, and R²⁴ are each independently selected from the group consisting of H, F, Cl, Br, CH₃, OCH₃, CH₂CH₃, OCH₂CH₃, CH₂CH₂CH₃, OCH₂CH₂CH₃, CH₂CH₂CH₂CH₃, CH(CH₃)₂, OCH(CH₃)₂, CH₂OCH₃, CH(CH₃)OCH₃, CH(CH₃)SCH₃, CF₃, OCF₃, CH₂CF₃, OCH₂CF₃, CF₂CH₃, OCF₂CH₃, CF₂CF₃, OCF₂CF₃, CH₂CH₂CF₃, OCH₂CH₂CF₃, CF₂CF₂CH₃, OCF₂CF₂CH₃, CF₂CF₂CF₃, OCF₂CF₂CF₃, CF(CF₃)₂, OCF(CF₃)₂, CF₂OCF₃, CF(CF₃)OCF₃, and optionally R²⁰ and R²¹ together form a (C₃-C₈)cycloalkyl; and (K) R¹⁶ and R¹⁷ along with C^(x)(Q²)(N^(x)), is (1g)

wherein, R¹⁸ and R¹⁹ are each independently selected from the group consisting of H, F, Cl, Br, CH₃, OCH₃, CF₃, OCF₃, NH₂, and NO₂.
 5. The molecule according to claim 1 wherein said molecule is No. Structure  F1

 F2

 F3

 F4

 F5

 F6

 F7

 F8

 F9

F10

F11

F12

F13

F14

F15

F16

F17

F18

F19

F20

F21

F22

F23

F24

F25

F26

F27

F28

F29

F30

F31

F32


6. A pesticidal composition comprising a molecule according to claim 1, further comprising an active ingredient having insecticidal, herbicidal, acaricidal, nematicidal, or fungicidal activity.
 7. A process to control a pest said process comprising applying to a locus, a pesticidally effective amount of a molecule according to claim
 1. 8. A process to control a pest said process comprising applying to a locus, a pesticidally effective amount of a pesticidal composition according to claim
 6. 9. The process according to claim 7 or 8, wherein said pest is beet armyworm (BAW), cabbage looper (CL), or yellow fever mosquito (YFM).
 10. The molecule according to claim 1 wherein at least one H is ²H or at least one C is ¹⁴C.
 11. A process comprising: orally administering; or topically applying; a molecule according to claim 1, to a non-human animal, to control endoparasites, ectoparasites, or both. 